Application of raman spectroscopy in pharmaceuticals by Zarow, Anna
New Jersey Institute of Technology
Digital Commons @ NJIT
Dissertations Theses and Dissertations
Spring 2011
Application of raman spectroscopy in
pharmaceuticals
Anna Zarow
New Jersey Institute of Technology
Follow this and additional works at: https://digitalcommons.njit.edu/dissertations
Part of the Chemistry Commons
This Dissertation is brought to you for free and open access by the Theses and Dissertations at Digital Commons @ NJIT. It has been accepted for
inclusion in Dissertations by an authorized administrator of Digital Commons @ NJIT. For more information, please contact
digitalcommons@njit.edu.
Recommended Citation
Zarow, Anna, "Application of raman spectroscopy in pharmaceuticals" (2011). Dissertations. 270.
https://digitalcommons.njit.edu/dissertations/270
 
Copyright Warning & Restrictions 
 
 
The copyright law of the United States (Title 17, United 
States Code) governs the making of photocopies or other 
reproductions of copyrighted material. 
 
Under certain conditions specified in the law, libraries and 
archives are authorized to furnish a photocopy or other 
reproduction. One of these specified conditions is that the 
photocopy or reproduction is not to be “used for any 
purpose other than private study, scholarship, or research.” 
If a, user makes a request for, or later uses, a photocopy or 
reproduction for purposes in excess of “fair use” that user 
may be liable for copyright infringement, 
 
This institution reserves the right to refuse to accept a 
copying order if, in its judgment, fulfillment of the order 
would involve violation of copyright law. 
 
Please Note:  The author retains the copyright while the 
New Jersey Institute of Technology reserves the right to 
distribute this thesis or dissertation 
 
 
Printing note: If you do not wish to print this page, then select  
“Pages from: first page # to: last page #”  on the print dialog screen 
 
  
 
 
 
 
 
 
 
 
 
 
 
The Van Houten library has removed some of the 
personal information and all signatures from the 
approval page and biographical sketches of theses 
and dissertations in order to protect the identity of 
NJIT graduates and faculty.  
 
  
ABSTRACT 
APPLICATION OF RAMAN SPECTROSCOPY IN PHARMACEUTICALS 
 
by 
Anna Żarów 
Experimental research on the use of Raman spectroscopy as an in- and on-line sensing 
tool and a complementary characterization technique for pharmaceutical applications is 
presented in this thesis. In the first chapter following a broad overview, the use of Raman 
spectroscopy, together with x-ray powder diffraction, scanning electron microscopy 
(SEM) and differential scanning calorimetry, for multilevel characterization of 
cryomilled powders, and the melt-grown amorphous phase of griseofulvin, a model 
active pharmaceutical ingredient (API), is presented and discussed in detail. A key 
feature was the observation of a broad inelastic background superimposed on the Raman 
spectra of cryomilled powders, which is attributed to lattice disorder and Mie scattering 
generated by mechanical processing and sub-micron particle interfaces. In the following 
chapter, polymorphs of another model API, acetaminophen (APAP), were studied by 
Raman spectroscopy with supporting information obtained from x-ray diffraction, SEM 
images and intrinsic dissolution profiles. An important result was the stabilization and 
characterization of the metastable type II orthorhombic phase of APAP which is highly 
desired for its unique tabletting properties which are important for pharmaceutical 
manufacturing. Stabilization of metastable type II APAP was achieved by micronizing or 
nanocoating stable monoclinic crystallites of type I APAP. In addition, as an Appendix to 
the thesis, micro-Raman spectroscopy of single crystal APAP as a function of crystal 
orientation and of temperature was measured to provide an understanding of the lattice 
properties of APAP for input into models to predict its behavior under mechanical 
 ii
milling conditions widely used in pharmaceutical processing. Molecular behavior 
obtained from the above studies guided simulated in-line and off-line characterization of 
griseofulvin as thin gel films made from micronized powders and nanosuspensions. By 
employing complementary near infrared and Raman imaging for newly developed films, 
it was possible to extract valuable information on the spatial distribution and crystallinity 
of the embedded particles in a polymeric matrix at different scales of scrutiny. 
Chemometrics processing of spectroscopic data for films and nanosuspensions allowed 
for qualitative and quantitative particle size determinations of the API’s in the films and 
nanosuspensions. In the final chapter a photonic crystal substrate for surface enhanced 
Raman spectroscopic (SERS) sensing was employed to detect and study griseofulvin and 
APAP down to 10-8 M levels with enhancement factors approaching 109. Detection 
sensitivities of the aromatic griseofulvin and APAP molecules were also compared with 
those of less aromatic and non-aromatic energetic molecules in order to understand the 
Raman enhancement process.  
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CHAPTER 1 
INTRODUCTION 
 
1.1 General Background 
The pharmaceutical industry, as one of the leading industries in the US, has experienced 
various challenges in the recent years. The number of drugs coming off patents and 
increase in generic drug availability is putting tremendous price pressure on domestic 
companies and their products. Quality issues are also at stake as the high number of 
recent recalls has severely damaged the reputation and reliability of the pharmaceutical 
industry. The need to increase the quality of the products due to numbers of recalls 
resulted in development of the Process Analytical Technology (PAT) initiative proposed 
by the US Food and Drug Administration (FDA). This initiative, which was first created 
in 2004 as an advisory for industry, will soon change into requirements to be adopted and 
followed.   
Defined by the FDA, PAT is “a system for designing, analysis, and controlling 
manufacturing through timely measurements (i.e., during processing) of critical quality 
and performance attributes of raw and in-process materials and processes with the goal of 
ensuring final product quality” [1]. Real time process control is a critical aspect of the 
PAT initiative especially since nanotechnology becomes a part of novel and innovative 
pharmaceutical products.  Process understanding and process control, robust design and 
built-in quality need to be integrated along the way at each stage of the manufacturing 
process to minimize widely used end-product or batch-to-batch testing. By implementing 
PAT, assessment of critical quality attributes of materials and products can be determined 
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early in the process development and allow for improvements and design of well- 
understood methodologies, ensuring high product quality throughout the continuous 
manufacturing process. Many analytical techniques are already used as in-process quality 
control tools, which includes a variety of physical techniques, such as diffraction, 
thermal, and spectroscopic methods applicable for macro-, micron- and sub-micron scale 
characterization. Used for solid state analysis, the analytical techniques provide 
understanding and knowledge on many complex phenomena at the molecular level (for 
example, polymorphism, disorder and defect-formation in molecular crystals, and 
chemical reactions), and at the batch-to-batch level during manufacturing (such as, 
granulation, drying and powder blending).  To fully execute the FDA’s PATs philosophy, 
these methodologies will require tools capable of operating at-line, on-line, and in-line 
stages and effectively utilize data processing management systems at all aspects of 
pharmaceutical development. Operating stages for the monitoring of manufacturing 
processes are presented in Figure 1.1 where the in-line analysis is shown to be performed 
at no physical contact between analytical system and the sample as the analyzer is located 
within the process. On-line analysis requires automated sampling and transfer to the 
automated analyzer. For at-line characterization, sampling is performed manually and 
transported to the analyzer located in the manufacturing area whereas in case of off-line 
analysis, the analyzer is located in the off-line laboratory. 
Vibrational spectroscopy, for example near-infrared (NIR) and Raman 
spectroscopy, has gained wide acceptance as fast, highly informative and non-destructive 
complementary methods for this purpose. These technologies can be placed at many 
interfaces of pharmaceutical processes to provide rapid, non-invasive real-time data.  
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Figure 1.1 Pharmaceutical processes monitoring [2]. 
 
 
Raman spectroscopy plays a significant analytical role in molecular level process 
understanding in the pharmaceutical industry. Process and bench-top applications have 
been developed using Raman spectroscopy and can be applied for qualitative and 
quantitative process evaluation.  Successful Raman spectroscopy applications in the 
pharmaceutical field include blend uniformity, reaction monitoring, solid quantification, 
coating monitoring and probably most significantly, crystallization monitoring and 
polymorph detection and analysis [3]. Significant technological development in the area 
of instrumentation has allowed the implementation of fiber optics, immersion and big 
spot size probes, and dispersive components into Raman systems, making them highly 
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robust and versatile tools for on-line and off-line characterization in the pharmaceutical 
industry [4].  
 This thesis, focused on the use of Raman spectroscopy as a characterization and 
sensing tool was part of a large effort supported by a National Science Foundation (NSF) 
funded Engineering Research Center (ERC) for Structured Organic Particulate Systems 
involving Rutgers University (lead), Purdue University, New Jersey Institute of 
Technology and the University of Puerto Rico at Mayaguez. The overall goal of the ERC 
was a national focal point for innovative science-based development of structured organic 
composite products and their manufacturing processes in the pharmaceutical industry.  
Work performed in this thesis was part of two projects within the ERC, one involving 
sensing for effective manufacturing and the other multilevel characterization of the 
composite products produced.  
 In this introductory chapter, the following sections will discuss the fundamentals 
of Raman spectroscopy in terms of its scientific background, instrumentation and 
techniques used in pharmaceutical research. Further, concepts of phase transitions in 
molecular crystals, the definition of the long- and short- range order in the solid state, and 
consequently the benefit of using the Raman technique to monitor 
crystallization/amorphization processes, will be discussed. The differences between 
Raman and fluorescence spectroscopy will also be illustrated. Other characterization 
techniques, such as Scanning Electron Microscopy (SEM), X-Ray Diffraction (XRD), 
and Differential Scanning Calorimetry (DCS) will be briefly introduced as they will be 
employed throughout this work to support the Raman spectroscopic data.    
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1.2 Raman Spectroscopy 
1.2.1 The Raman Effect 
In 1928, Sir Chandrasekhara Venkata  Raman along with his colleague, Kariamanickam 
Srinivasa Krishnan, discovered “a new type of secondary radiation” [5] in sixty different 
common liquids. They observed a shift in the color of light scattered to some degree in 
most of the liquids simply by probing the samples with concentrated sun light. For this 
discovery, C. V. Raman was awarded the Nobel Prize in Physics in 1930 and the 
phenomenon that described the inelastic exchange of energy between light and matter 
was later named the Raman Effect.  
When light interacts with matter, it can be either absorbed or scattered. During the 
scattering process, the majority of the light is scattered elastically at the same frequency 
and with no energy transfer between light and the molecule or solid. This is known as 
Rayleigh scattering. However, when the oscillating electric field of the incoming 
radiation interacts with molecules or the solid, there is also a small but finite possibility 
of the molecule or solid retaining the incoming photon’s energy and generating 
vibrational excitations. This interaction is known as inelastic scattering of light or 
spontaneous Raman scattering when the interaction is non-resonant.  The phenomenon is 
a low probability event and only 1 out of 107 photons will undergo inelastic scattering. 
During the interaction, the energy carried by incoming photons excites vibrational states 
within a molecule or a solid by distorting the electron clouds around molecular or 
intermolecular bonds in a solid. This shift in electron cloud distribution results in a 
change in bond polarizability (α) and induces a temporary dipole moment (P) and excites 
the molecule or solid into a virtual excited state when the interaction is non-resonant. 
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Since excited states do not have infinite lifetime, the scattering events occur in 10-12 
seconds or less [6] after which the molecule or solid relaxes back to its ground state, 
emitting a photon at a specific frequency (ννib).  
Depending on the energy difference between the original and the relaxed states, 
there is a change in the frequency of the emitted light from that of the incident light. 
Molecules or solids that relax back to the pre-excited state emit the same frequency (ν) 
light to give rise to elastic scattering. Molecules or solids that relax to a different 
vibrational state, however, emit a photon of different energy to give rise to inelastic 
scattering. This generated photon is shifted in frequency by an amount corresponding to 
the energy of a particular vibrational transition. If the final state is more energetic than 
the initial state, the emitted photon will be shifted to a lower energy (ν-ννib) which is 
designated as a Stokes shift. If the final state is less energetic, the emitted photon will be 
shifted to a higher frequency (ν+ννib) resulting in an anti-Stokes shift as shown in Figure 
1.2. Such a change in energy gives rise to inelastic scattering of photons. The energy 
difference corresponds to a vibrational or rotational (librational in the case of solids) 
frequency of a molecule within gaseous, liquid and solid states, or of vibrations between 
molecules or ions in a solid, and is referred to as the Raman Effect.  
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Figure 1.2 Rayleigh, Raman Stokes and anti-Stokes scattering, and fluorescence energy-
level diagram.  
 
The theory behind the Raman effect was derived by Austrian physicist, Adolf 
Smekal, five years prior to its discovery by C. V. Raman, who predicted the existence of 
stray lines with shifted frequencies [7]. Mathematical representation of Raman scattering 
can be expressed in terms of induced dipole moment in a diatomic molecule. The strength 
of the induced dipole moment (P) depends on the electrical field (E) of the incident 
electromagnetic radiation: 
P = αE      (1.1) 
where α is the polarizability tensor of the molecule that measures the ease with which the 
electron charge cloud around the molecular bond is distorted. Considering the molecule 
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in the external electric field in terms of wave mechanics, one finds that the induced dipole 
moment is given by [6]: 
P = α0E0cos(2πνt) + 
02
1






q

q0E0cos(2π(ν+ννib)t) + 
02
1






q

q0E0cos(2π(ν-ννib)t)   (1.2) 
 Rayleigh         anti-Stokes            Stokes  
 
0

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



q
 - Rate of change of α with respect to the change in q at equilibrium position 
The first term represents an oscillating dipole that elastically scatters the light of 
frequency (ν) corresponding to Rayleigh scattering. Induced dipole moments are created 
at distinct anti-Stokes (ν+ννib) and Stokes (ν-ννib) frequencies to give rise to inelastic 
scattered radiation at these frequencies.  The necessary condition for Raman scattering to 
occur requires the bond polarizability to change as a function of bond length variation 
during the vibration. This is given by the polarizability derivative, 
0






q
 which is non-
zero for a Raman-active vibration.   
1.2.2 Raman Instrumentation and Techniques 
Raman spectrometers can be either dispersive (for light sources in the visible and near-
infrared range) or interferometer systems (for light sources in the infrared range). Most 
commonly used systems are dispersive and consist of a notch or edge filter for rejection 
of Rayleigh scattering, a monochromator for dispersion of the scattered radiation and a 
charge coupled device (CCD) array for photon detection as depicted in Figure 1.3 (a).  
The sample is excited with a laser source in the ultraviolet (UV), visible (Vis) or near 
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infrared (NIR) range, passed through a notch filter or monochromator to eliminate the 
intense Rayleigh scattering. The Raman resulting signal is then sent via a grating 
spectrometer to a CCD detector.  
 
(a)                                                                     (b) 
 
 
 
 
 
 
Figure 1.3 Raman spectrometers in: (a) Fiber optic and (b) Confocal geometries. 
 
Raman sampling is a fast process and requires only a few seconds for a spectrum 
to be acquired to provide a wealth of information concerning the chemical composition 
and structure of the probed region. Optical fibers allow for remote or stand-off sample 
sensing since both the laser and scattered light travel through the same fiber optic probe. 
A micro-Raman spectrometer, although not designed for remote sampling, couples the 
spectrometer and incident light source to an optical microscope, thus allowing Raman 
analysis with a microscopic laser spot size which is ideal for probing micron to sub-
micron scale sample features.  
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The sub-micron spatial resolution achieved by a Raman microscope allows for 
analysis of the solid state structure, and the spatial distribution of polymorphs and active 
particles in a composite. Combining the micro-Raman analysis with an automated stage 
allows the creation of a chemical map of a composite sample [8]. During mapping, a 
complete Raman spectrum is obtained for each pixel of the image and since each 
spectrum represents the fingerprint of a chemical species, the distribution of different 
materials and/or their local properties can be analyzed.  By placing a small confocal 
pinhole in the focal plane of the microscope as indicated in Figure 1.3 (b), axial 
resolution can be further improved by allowing collection of spectra from a sample 
volume and creating depth profile of a sectioned specimen [9, 10].    
In Fourier Transform (FT)-Raman spectroscopy an interferometer is used to 
produce an interferogram to encode the unique frequencies of the Raman spectrum into a 
single signal. The advantage of FT-Raman spectroscopy is mostly due to the use of an 
infrared laser (typically at 1064 nm) as the excitation source which minimizes the laser-
induced fluorescence in the sample that can interfere with the weak Raman signal.  
Several types of Raman spectroscopy have been developed to enhanced its sensitivity 
and improve spatial resolution. In this thesis, Surface Enhanced Raman Spectroscopy 
(SERS) will be discussed as a technique for improved detection limits through 
enhancement of the Raman signal from Raman-active analyte molecules adsorbed on 
gold coated photonic crystal-type arrays.  The enhancement of the weak Raman signal by 
SERS relates primarily to two mechanisms:  an electromagnetic enhancement induced by 
coupling to surface plasmons and a chemically-induced enhancement [11]. Chapter 5 will 
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discuss is some detail the basic principles behind SERS and illustrate its applications for 
rapid trace detection of pharmaceuticals and related organic molecules.  
 
1.2.3 Raman Effect  in Relation to Structural Disorder, Phase Transitions, and 
Particle Size 
 
Modern Raman spectroscopy uses laser light sources to generate elastic and inelastic 
scattering to obtain vibrational spectroscopic information about molecules and solids. 
The so-called spectral fingerprint region in the 700 to 1900 cm-1 frequency range contains 
information about the frequencies or energies of key molecular vibrations. In addition, 
information about molecular rotations, and translations and hindered rotations (or 
librations) in a solid, is obtained from spectra below 200 cm-1. The vibrational energies or 
frequencies depend on the mass of particular atoms in a molecule or an ion in an ionic 
solid, the nature of the chemical bonds connecting them, the symmetry of the molecular 
structure in a gas or liquid, and the local structure of the environment where they reside 
in a crystalline solid (Figure 1.4). 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 Schematic depictions of three types of order in a solid: (a) A periodic array 
with long-range order as in a crystalline solid; (b) A periodic array in a defected solid 
with short-range order, and (c) An amorphous solid.   
 
 
(a) (b) (c) 
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Crystalline solids are composed of atoms/molecules or ions arranged in periodically 
repeating unit cells. This order, which is of long-range in bulk solids is linked to their 
optical, electrical, magnetic and mechanical properties. X-ray powder diffraction (XRPD) 
is routinely used to determine the crystallinity and average particle size in polycrystalline 
powders. However, many imperfections reside at short ranges which can be overlooked 
by XRPD. Among the most common imperfections in the crystalline lattice are point, 
linear, and planar defects that occur naturally in many materials [12] and can also be 
induced by mechanical processing via stress-induced perturbations. Induced disorder or 
defects at short range can propagate through the solid to give rise to longer range disorder 
or amorphization. Raman spectroscopy can provide information on structural variations 
at the molecular, short range scale and on crystallite sizes below the quantum localization 
limit through change of the intensities, frequencies, and linewidths of characteristic 
Raman lines. Moreover, decrease in line intensities can occur due to increased sizes of 
particles in a suspension because of decreased light throughput or increase diffuse 
reflectance [13]. This methodology can be used to determine the average particle size on-
line in a suspension from calibration curves obtained on control samples using light 
scattering methods.      
The Raman spectrum provides key structural information at various frequency ranges. 
It determines intra- and inter- molecular vibrations that correspond to different frequency 
ranges as depicted in Figure 1.5. In the crystalline state, it is involved with both 
molecular and inter-molecular translational and hindered molecular rotational or 
librational vibrations. In the solid state, the Raman-active vibrations are small wave 
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vector (k=2/, where  is the wavelength) optical phonons, which are quantized 
collective vibrational excitations superimposed on each other as plane waves and 
propagating throughout an individual crystal. These vibrations are grouped into 
molecular vibrations that involve  stretching (ν), bending (δ), and torsional (τ) 
oscillations, and lattice vibrations consisting of librational (hindered rotational) and 
translation motions. For compositional identification, molecular modes are typically  
 
 
 
 
 
 
 
 
 
 
Figure 1.5 The Raman spectrum of a typical organic solid and the broad inelastic 
scattering background component associated with structural disorder. Information 
obtained from the data is also indicated.   
 
studied since they are most sensitive to bond length and symmetry changes, and 
substitution of atoms, therefore giving information about the molecular structures 
involved [14].  
 Lattice modes are sensitive to the structural arrangement of the solid since they 
correspond to relative motions of the molecular units or ions in a unit cell of the lattice 
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[15]. These motions are categorized based on the direction in which the neighboring 
atoms oscillate. For Raman-active optical phonons, the vibrations correspond to 
transverse oscillations whereas acoustic phonons that are observed optically by Brillouin 
scattering at low k and at higher k by neutron scattering, oscillate longitudinally.   
The total number of phonons propagating in a primitive crystal containing N unit 
cells each with p atoms is given by 3pN-6 (where the number of acoustic and optical 
modes is 3 and 3pN-3, respectively).  The corresponding wave vectors (k) belong to a 
volume of reciprocal space referred to as the Brillouin zone (BZ) [16]. Raman-active 
optical phonons in a crystalline solid occur at k0. However with decreasing crystallite 
size down to the amorphous level where long range order is lost, this rule is no longer 
valid and all phonons contribute to Raman scattering resulting in broad lines, frequency 
shifts and line asymmetry [17]. In the nanocrystalline phase, however, the situation is 
somewhat intermediate and the Raman spectrum displays broadened crystalline features 
which are shifted due to phonon confinement at the nanoscale [17, 18]. In addition, the 
symmetry of bulk crystalline materials can be broken in nano-crystals due to the high 
concentration of grain boundaries (coincident lattices), which also causes the appearance 
of specific surface modes as reported for silicon by Veprek et al [18]. In the case of 
nanocrystalline silicon it is found that below 3 nm a discontinuous transition to the 
amorphous phase occurs [16-18]. 
Raman spectroscopy is widely used for qualitative and quantitative characterization 
of polymorphs; it is also used to determine particle sizes in suspensions via changes in 
line intensity, crystal quality by monitoring linewidth and stress or strain by monitoring 
line frequencies (Figure 1.6). By definition, a polymorph is a crystal that can exist in two 
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or more crystalline phases, each having different crystal structures [19]. Phase 
identification is important because the material properties are highly dependent on 
structure. Raman spectra of polymorphs show changes in vibrational frequencies mainly 
because of different molecular and crystal symmetries in each polymorph due to changes 
in inter-molecular interactions influence the vibrational energies of each crystal structure. 
Amorphous forms loose long range order and give rise to broad lattice mode Raman  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 Changes in Raman lines due to: (a) Polymorphism – change in Raman peak 
frequencies, (b) Amount of material – change in intensity of Raman line, (c) Quality of 
crystal – change in Raman linewidth, (d) Application of stress or strain state – change in 
Raman line frequency. 
 
spectra, although Raman lines due to molecular modes in the amorphous phase of organic 
crystals broaden but remain discrete since the molecules themselves are largely 
 
(c) (d)
(a) (b)
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unchanged. Intrinsically, spectral linewidths are inversely proportional to the lifetime of 
an excited state following the Heisenberg Uncertainty Principle [20]. Therefore, in bulk, 
highly crystalline solids, the excited states are long-lived and give rise to spectra with 
small linewidths. For example, by taking a Raman excited state lifetime of 10-12 seconds 
for single crystal silicon, the calculated peak width is 5 cm-1, which is in agreement with 
the experimentally measured values for Raman scattering from single-crystal Si by 
Parker et al [20]. The phenomenon of phase transitions will be discussed further in 
Chapter 3.  
Characterization at the Raman level as described above can provide better 
pharmaceutical products with innovative technologies involving drugs with nano-
technological input. In order to build quality into these novel drugs, one therefore needs 
to have a thorough understanding of the material’s behavior during manufacturing 
processes (including mechanical and chemical changes) and this is a critical aspect for 
building better quality products.  
1.2.4 Distinguishing Raman Scattering from Fluorescence 
The intensity of the Raman signal is proportional to the 4th power of the excitation 
frequency. Short excitation laser wavelengths deliver highly intense Raman signals; for 
example, exciting a sample with blue light (400 nm) will give a Raman signal that is 16 
times stronger than that obtained using red light at 800 nm. However, when using laser 
excitation wavelengths below 600 nm results in intense first order fluorescence from the 
samples.  
Raman scattering, which is a weak effect, is often overshadowed by fluorescence 
emission from the sample arising from competing phenomena with similar origins but 
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higher cross-sections. In Raman spectroscopy, the laser photon interacts with a molecule 
in its ground electronic state with and without thermal excitation to gain (the anti-Stokes 
process) and lose (the Stokes process), respectively, a certain amount of energy 
corresponding to a vibrational frequency of the molecule via a virtual excited electronic 
state.  The various frequency shifts associated with different atomic vibrations in the 
molecule give rise to a Raman spectrum that is unique for a specific molecule. The 
Stokes spectrum is typically more intense than the anti-Stokes spectrum because a 
smaller fraction of the molecules are thermally excited at room temperature. 
In spontaneous, non-resonant Raman spectroscopy, the interaction of the photon 
and its re-emission occurs almost instantaneously (10-12 seconds or less) after excitation 
to a virtual excited state of the molecule followed by relaxation to vibrational states of the 
ground electronic level to generate a Raman spectrum on the higher (anti-Stokes) and 
lower (Stokes) energy side of the elastic Rayleigh scattering. The spectrum comprises of 
narrow emission lines associated with the vibrational modes of the molecule. The intense 
Rayleigh scattering is filtered out by a single or double monochromator, coupled to an 
optical notch filter. In contrast, fluorescence emission takes place by an absorption 
process to real electronic energy levels of the molecule followed by rapid relaxation from 
electronic and vibrational states down to the excited vibrational levels of the ground state 
as in Raman scattering. Therefore although the mechanism is different, the net result of 
both processes is essentially the same and in both cases a photon of energy with the 
frequency different from that of the incident photon is released by bringing the molecule 
to a higher or lower energy level. In fluorescence, the photon energy is absorbed by the 
molecular species from its ground electronic state to one of the various vibrational states 
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in the excited electronic state as shown in Figure 1.2. Following this, collisions with other 
molecules cause the excited molecule to lose vibrational energy until it reaches the lowest 
vibrational state of the excited electronic state. The molecule then drops down again to 
one of the various vibrational levels of the ground electronic state, emitting a photon in 
the process. Since the molecules can drop down into any of several vibrational levels in 
the ground state, the emitted photons will give rise to a broad envelope of different 
energies or frequencies. The lifetime of the excited state is much longer (ca. 10-8 to 10-5 
seconds) [6] from which the molecule relaxes into various lower energy states, to produce 
the fluorescence spectrum. This results in high intensity, but lower chemical specificity 
because a broad envelope of energies is emitted. Moreover, fluorescence involves a 
resonant process between real electronic states and is therefore strongly dependent on the 
frequency or wavelength of the incident light [21]. The Raman effect on the other hand is 
typically spontaneous and excitation wavelength independent. It is a relatively weak 
process involving virtual states mediated by the molecular vibrations and associated with 
change in bond polarizability. 
 
1.3 Other Characterization Techniques  
Although the focus of this work is primarily on the use of Raman spectroscopy to 
characterize and study pharmaceutical powders, films and suspensions, other advanced 
analytical and imaging tools were also employed throughout this research. In the 
pharmaceutical industry these advanced methods are often used concomitantly in order to 
overcome the complex challenges of data interpretation and provide a more complete 
picture of the solid-state.  This approach has also been employed in this research since 
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solid-state analysis requires more than one technique for effective analysis.  In the 
following sub-sections, some of the techniques used will be briefly discussed while 
others will be considered in more detail in some of the following chapters.  
1.3.1 Scanning Electron Microscopy (SEM) 
Scanning Electron Microscopy (SEM) involves a high resolution microscope that uses a 
high-energy beam of electrons instead of light to form an image. This technique allows 
for physical characterization of the material surface as the signal results for the electron’s 
interaction with the atoms at the sample surface. Since the magnetically focused beam of 
electrons is very narrow, SEM records microscale to nanoscale images with large depth 
of field, resulting in a three-dimensional appearance with spatial resolution on the order 
of 5 nm in the best microscopes. Physical characteristics, such as particle size, shape, and 
morphology of an active pharmaceutical ingredient (API) and associated excipients are 
important for pharmaceutical process understanding as they can influence the dissolution 
profile and drug bioavailability. Typical SEM images provide nanoscale visualization of 
the surface structure and morphology of pure and composite solids. Throughout this 
research SEM images were obtained with a VP-1530 Carl Zeiss LEO (Peabody, MA) 
field emission scanning electron microscope. The samples, which were all non-
conducting, were mounted on aluminum stubs using double-sided carbon tape and 
sputter-coated with carbon to avoid charging.  
1.3.2 X-Ray Powder Diffraction 
X-Ray Powder Diffraction (XRPD) is a powerful technique that besides phase 
identification is largely used for determining the first order crystal structure, average 
crystallite size and stress in polycrystalline powders and composites.  The small 
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wavelength of X-rays used to probe the sample, typically 1.54Å for CuK radiation in 
laboratory instruments, is comparable to inter-atomic distances and therefore gives 
structural arrangements of atoms and molecules when single crystal diffraction 
techniques are employed. To probe wider ranges in k space using XRPD, a small angle 
Synchrotron X-ray light source is used. In this thesis, laboratory scale wide angle XRPD 
and small-angle Synchrotron XRPD studies were performed to investigate the effect of 
mechanical milling on sample crystallinity and correlate the scale of structural changes 
with Raman results.  For example, in Chapter 3, XRPD was used to confirm crystallinity 
and structure of the newly developed stable phase of acetaminophen.     
  All samples investigated in this study were analyzed using a wide-angle Philips 
X’pert PW3040 X-Ray Diffractiometer with CuKα radiation (λ =1.5406 Å) operated at 
40kV and 30mA, with 2θ ranging from 5° to 50°. Temperature-dependent small-angle 
Synchrotron X-ray powder diffraction measurements were conducted at the beam line 
X10A (λ=1.097Å) with a CCD detector at the National Synchrotron Light Source 
(NSLS), Brookhaven National Laboratory on a micronized griseofulvin sample as 
discussed in Chapter 2. The data were interpreted using parameters obtained from an 
Al2O3 reference. 
1.3.3 Differential Scanning Calorimetry (DSC) 
Thermal analysis techniques measure the physical stability and phase transitions of drug 
products and excipients during heat exposure. In particular, differential scanning 
calorimetry (DSC) measures the amount of heat required to increase the sample 
temperature in reference to the standard material. For polymorphs, the chemical entity 
remains the same but physical properties, such as density, melting point, or heat capacity 
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can vary due to different crystal packing from one polymorph to another. DSC is widely 
used for the initial detection and quantification of polymorphs since it measures the 
enthalpy term, ΔH, associated with the lattice energy difference [22]. In this study, DSC 
was performed with a FP900 Thermo System (Mettler-Toledo, Columbus, OH) 
comprising of a FP90 Central Processor and FP84HT TA Microscopy Cell.  Sample 
weights were kept in a range between 6 to 8 mg and were heated at 5°C/minutes to a 
temperature exceeding the melting point of griseofulvin at 230°C.  
 
    1.4 Summary of Chapters to Follow  
After this brief introduction to Raman spectroscopy in Chapter 1, Chapter 2 will discuss a 
multilevel characterization approach for processed pharmaceutical powders concentrating 
on structural disorder in cryomilled and amorphous griseofulvin. Cryogenic milling used 
to reduce particle size of soft crystals was observed also to induce structural disorder in 
griseofulvin indicated by broad inelastic Raman scattering and changes in intensities and 
splittings of some of the Raman lines with increasing levels of disorder [23]. Chapter 3 
will discuss how process design can potentially utilize polymorphs, such as those of 
acetaminophen (APAP). The type II polymorph of APAP is metastable but highly 
attractive for pharmaceutical applications since it compresses and dissolves better than 
the stable type I polymorph. Novel behavior was observed for type II APAP prepared 
from milled and nano-coated acetaminophen powders. In addition, an oriented single 
crystal study of the behavior of Raman-active APAP vibrations as a function of 
temperature will be presented in Appendix A. Under favorable conditions of temperature, 
APAP can undergo a phase transition of the stable type I phase into metastable type II, 
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highly unstable type III, or even the amorphous type. Temperature-dependent molecular 
data of this type coupled with stress-dependent data obtained elsewhere can help generate 
predictive models for the behavior of crystallites of active pharmaceutical ingredients 
during manufacturing processes.  
 Applications of Raman spectroscopy as an on-line and in-line sensing tool will be 
presented in Chapter 4. They will be combined with off-line results of complementary  
Raman mapping and near IR chemical imaging which will be compared and analyzed for 
griseofulvin particle distribution, quantification and defect formation in newly developed 
polymeric films for pharmaceutical applications [24]. Chapter 5 will finish the thesis by 
illustrating the use of SERS phenomena induced by surface plasmon resonance for rapid 
trace detection of pharmaceuticals, and related organic molecules used in energetic 
formulations [25]. The closing Chapter 6 will provide a broad overview summary of the 
results obtained and suggestions for future work.   
 
 
23 
 
CHAPTER 2 
SPECTROSCOPIC AND X-RAY DIFFRACTION STUDY OF STRUCTURAL 
DISORDER IN CRYOMILLED AND AMORPHOUS GRISEOFULVIN 
 
2.1 Objective 
Structural disorder induced by cryogenic milling and by heating to the amorphous phase 
in the active pharmaceutical ingredient, griseofulvin, has been studied by Raman 
spectroscopy, X-ray powder diffraction (XRPD) and fluorescence spectroscopy. A broad, 
exciting frequency-independent scattering background in the Raman spectra and changes 
in intensities and splitting of some of the Raman lines due to lattice and molecular modes, 
have been observed. In the cryomilled samples this strong background is deconvoluted 
into two components: one due to lattice disorder induced by cryomilling and the other 
due to Mie scattering from nanosized crystallites. A single-component background 
scattering attributed to lattice disorder is seen in the Raman spectrum of the amorphous 
sample. Fluorescence measurements showed an intrinsic fluorescence signal in as-
received griseofulvin that does not correspond to the inelastic background in the Raman 
spectra, and moreover decreases in intensity on cryomilling, thus excluding an 
assignment of the Raman background intensity to impurity- or molecular defect- induced 
fluorescence. Wide-angle XRPD measurements on cryomilled griseofulvin shows a broad 
two-component background consistent with the background scattering component in the 
Raman data associated with lattice disorder at longer correlation lengths. Persistence of 
this disorder to even longer correlation lengths is evident from small-angle Synchrotron 
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XRPD data on micronized griseofulvin, which were taken as a function of temperature as 
the sample changes from the crystalline to the amorphous phase.  
 
2.2 Introduction 
Milling is widely used by the pharmaceutical industry to reduce the particle size of active 
pharmaceutical ingredients (APIs). Size reduction leads to increase in the surface to bulk 
ratio of the particle which enhances its bioavailability and dissolution rate. During 
milling, however, mechanical stress can induce changes in the crystal lattice of the API 
which will modify its physical and chemical properties. Both ball and jet milling, 
commonly used by industry, can affect crystal morphology and induce structural disorder 
[26]. These changes can cause crystal defects that are believed to mostly exist at the 
surface of the crystallites [27] and may originate from molecular conformational changes 
or unit cell distortions. Many types of defects exist and the most common ones include 
those due to varying grain sizes, edge dislocations and grain boundary effects [28]. 
Crystalline defects act as higher energy sites that are thermodynamically unstable 
compared to those in the stable crystalline form. Defects can progressively transform 
during processing into longer range disorder in atomic positions resulting eventually in 
the formation of an amorphous phase or a polymorph [29].  
 Raman spectroscopy is particularly sensitive to structural changes, see Chapter 1. 
The first order lattice or inter-molecular modes observed in Raman spectra typically 
occur at frequencies below 200 cm-1 [30, 31]. Lattice modes include translational and 
librational vibrations that are very sensitive to structural disorder and polymorphism. 
Intra-molecular deformation, rocking wagging, breathing and stretching modes which 
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typically lie in the frequency range above 200 cm-1 [32] are also sensitive to changes in 
the local crystal field caused by disorder or polymorph formation [33]. Therefore, 
changes in peak positions and intensities or the appearance of new lines in the Raman 
spectra would indicate the formation of defects or disorder, an amorphous phase or a new 
structural polymorph [34-36]. In addition, structural defects or disorder in the crystal may 
generate background scattering in the Raman spectra and diffuse scattering superimposed 
on X-ray diffraction patterns that resemble X-ray scattering from amorphous solids [18, 
37-39]. Background intensity in Raman spectra is often caused by fluorescence when the 
excitation wavelength is close to an intrinsic electronic transition in the sample or it is 
caused by impurities introduced during processing or sample preparation. In both these 
cases the background intensity would vary with the excitation wavelength used. If the 
scattering background is excitation frequency-independent it may be attributed to other 
possibilities, especially if the material had undergone mechanical processing that can 
produce structural defects or disorder.   
 In the present study, cryomilled griseofulvin was investigated for defect and 
disorder formation and structural stability using spontaneous Raman scattering and X-ray 
powder diffraction (XRPD) techniques. Prior work by Bates et al [37] and Yamamura et 
al [38] focused primarily on x-ray diffraction studies of disorder in organic crystal 
systems, whereas Veprek et al [18] investigated the transition to the amorphous phase in 
silicon, a covalently bonded inorganic crystal, using both x-ray diffraction and Raman 
spectroscopy. In this paper, Raman spectroscopic and diffuse inelastic light scattering 
data have been obtained and correlated with x-ray diffraction and scattering data obtained 
from polycrystalline samples of as-received and processed griseofulvin, an organic solid, 
26 
 
 
and from amorphous griseofulvin. Quantitative estimates of crystallinity and particle 
sizes were obtained by differential scanning calorimetry (DSC) and from scanning 
electron microscope (SEM) images, respectively. The Raman spectra were examined 
using two different Raman instruments with different excitation wavelengths in order to 
rule out fluorescence and other extraneous effects in the data. Fluorescence spectroscopy, 
and wide-angle XRPD and small-angle XRPD using a Synchrotron source were also 
conducted. Laser and high humidity annealing experiments were performed to understand 
the nature of the defects and disorder induced by cryomilling. In laser annealing, heat is 
applied locally to form a thin solid-liquid interface not commonly formed in bulk thermal 
treatment. Laser annealing using rastering and broadening of the laser beam is therefore 
capable of rapidly removing defects and disorder [39]. The overall objective of the 
present work is to develop fast and non-destructive characterization of APIs like 
griseofulvin to detect mechanically-induced defects or disorder which could initiate the 
growth of undesirable polymorphic forms [40-42].  
 
2.3  Experimental Materials and Methods 
2.3.1 Materials 
Crystalline Griseofulvin: Obtained from Sigma-Aldrich (St. Louis, MO) and stored at 
0ºC in a freezer.  Commercially available micronized griseofulvin, USP grade, was 
purchased from Spectrum Chemical (Gardena, CA) and also stored at 0ºC in a freezer.  
Cryomilled Griseofulvin: Samples of cryomilled griseofulvin were prepared using 
cryogenic milling which was performed with a SPEX CertiPrep 6750 cryogenic impact 
mill (Metuchen, NJ) as described in reference [34]. The mill consisted of a cylindrical 
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vessel made out of polycarbonate within which a stainless steel rod was vibrated by 
means of an oscillating magnetic field.  Liquid nitrogen was used to pre-cool 2 g of 
crystalline griseofulvin. After pre-cooling, the sample was milled in five cycles of 2 
minutes milling and 2 minutes cooling. This milling process was repeated three times. 
Upon completion, the cryomilled material was placed in a cold water bath for around 10 
minutes until it reached room temperature. It was then stored in a desiccator at 0oC. Three 
cryomilled samples, referred to as samples 1, 2 and 3 in the text were prepared under 
these conditions.   
Amorphous Griseofulvin: Two amorphous griseofulvin samples were prepared for this 
study, one from crystalline Sigma-Aldrich griseofulvin and the other from cryomilled 
griseofulvin. To obtain the amorphous form, small amounts of each sample were placed 
on a glass slide, heated on a hot plate at 220ºC (slightly above the melting point of 
218ºC) until completely melted and then allowed to cool rapidly to room temperature to 
form a clear solidified film on the glass slide. Raman spectra were run immediately after 
preparation of the amorphous samples. The appearance of a strong peak at 656 cm-1 in the 
Raman spectra was used to confirm the formation of amorphous griseofulvin.    
2.3.2 Methods 
Raman Spectroscopy: Two different Raman instruments were used to collect Raman 
spectra: (a) A confocal Horiba- Jobin Yvon LabRam micro-Raman spectrometer with a 
20 mW He-Ne laser source emitting at a wavelength of 632.8 nm focused to a spot size of 
10 µm with a 10x lens; and (b) A Mesophotonics SE (Southampton, UK) 1000 Raman 
spectrometer calibrated to 2 cm-1 with a 250 mW near-infrared laser operating at 785 nm 
with a 130 µm diameter spot size.  
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Typical acquisition time for all spectra recorded was 10 sec per scanned spectrum. 
Each spectrum acquired using the Horiba-Jobin Yvon LabRam micro-Raman 
spectrometer was averaged over 2 scans. Data acquired with the Mesophotonics SE 1000 
Raman spectrometer represent an average of 5 scans, for a total of 50 seconds. All Raman 
data shown are as-recorded by the instruments used.  During spectral acquisition, powder 
samples were placed on glass substrates, whereas amorphous samples were both prepared 
and analyzed on glass substrates. 
Spectral Deconvolution: The inelastic scattering Raman background and diffuse X-ray 
scattering background were fitted using a multi-peak fitting package provided in IGOR 
Pro software from WaveMetrics, Inc. (Lake Oswego, OR). Deconvolution was performed 
using both Lorentzian and Gaussian functions. 
Annealing Procedures: The annealing of cryomilled griseofulvin samples was 
performed using two different methods – laser irradiation and exposure to high humidity 
conditions. The effects of the annealing were then monitored by Raman spectroscopy.  
Laser annealing was performed using 20 mW of focused 632.8 nm radiation from a He-
Ne laser in the Horiba-Jobin Yvon LabRam micro-Raman spectrometer. Each sample 
was exposed to constant laser radiation for a total of 30 minutes, with spectra being 
obtained periodically. The initial spectrum was recorded prior to the laser treatment and 
the final spectrum was recorded upon completion of laser exposure.   
Samples for monitoring the effect of high humidity were placed in a sealed 
desiccator along with a beaker containing approximately 50 mL of boiling hot de-ionized 
water and a humidity meter from Taylor Indoor Humidiguide (Las Cruces, NM). 
Humidity levels were maintained at 70-80% and the water was boiled again whenever the 
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humidity level dropped below 70%. The temperature was maintained between 21 - 23°C. 
Small amounts of sample were removed periodically for Raman measurements using the 
Mesophotonics SE 1000 Spectrometer and were disposed of after each measurement. 
X-Ray Powder Diffraction: See Chapter 1 for wide-angle Philips X’pert PW3040 X-
Ray Diffractiometer and small-angle Synchrotron X-ray powder diffraction 
measurements details.  
Scanning Electron Microscopy (SEM): See Chapter 1 for details.   
Differential Scanning Calorimetry (DSC): See Chapter 1 for details. 
Fluorescence and UV-Vis Spectroscopy: Solid state fluorescence spectra were acquired 
at room temperature using a Hitachi F-3010 Fluorescence spectrophotometer 
(Schaumburg, IL) with a Xe lamp. The spectra were measured at a 60 cm-1/minutes 
spectral rate and excitation wavelength (λex) of 300 nm. The UV-Visible absorption 
spectrum corrected for the solvent signal was acquired with a Varian Cary 50 Bio UV-
Visible spectrophotometer (Palo Alto, CA) using a 3 ppm solution of griseofulvin in 
acetone in a 3 ml quartz cuvette.  
2.4 Results and Discussion 
2.4.1 Scanning Electron Microscopy  
Because particle size and shape can affect the Raman and XRPD data obtained, SEM 
imaging of the different griseofulvin samples were carried out. Representative SEM 
images from as-received micronized and cryomilled griseofulvin sample no. 3 used in 
this study are shown in Figures 2.1 (a) and (b), respectively. Reduction in crystallite sizes 
from the breakup of the rod-like particles in the micronized sample can be seen on 
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comparing the images. For example, the arrowed regions show fine grains in the 
nanometer size range for the cryomilled sample. 
2.4.2 Raman Spectra of Crystalline, Cryomilled and Amorphous Griseofulvin 
Crystalline molecular solids, such as griseofulvin, have the molecules organized in stable 
low energy conformations and in periodic arrays to produce an ordered lattice with inter- 
and intra-molecular vibrations which interact with light to give rise to well-resolved 
Raman spectra. This highly ordered structure can change under processing or high 
temperature conditions to a new crystalline structure, a defected or partially disordered  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 SEM images at a magnification of 100,000 of griseofulvin samples used. 
Panel (a) shows a typical image for commercially micronized griseofulvin and panel (b) 
show an image for cryomilled griseofulvin. Arrows indicate nano-sized grains in the 
cryomilled sample. 
 
version of the structure, or an amorphous solid where the molecules are oriented in a 
random fashion while still maintaining their original stable conformation or a new 
conformation stabilized in the newly disordered lattice potential. The inter-molecular 
lattice modes of the crystalline phase are replaced by large amplitude diffusive or 
relaxational modes in the amorphous phase [43].  The lattice mode Raman lines of the 
(a) (b)
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crystals broaden substantially in the amorphous phase whereas the intra-molecular 
vibrational lines remain largely unchanged if there is no change in molecular 
conformation. Typically, however, there are changes in molecular conformation and 
inter-molecular hydrogen bonding interactions in the amorphous phase and in 
polymorphs, resulting in shifts in line frequencies, linewidth broadening and changes in 
line intensities. In the case of a defected structure, the Raman spectrum will depend on 
the nature of the defects formed. Localized molecular defects would give rise to new 
lines in the molecular vibration frequency region coupled with excitation wavelength 
dependent fluorescence superimposed on the Raman spectrum as a broad signal. Crystal 
defects, such as dislocations and orientational defects of the type discussed by Feng et al 
[34] will most likely occur at grain boundaries created by milling. These defects give rise 
to longer range disorder manifested as a scattering background in the XRPD data, 
whereas shorter range disordered domains will give rise to a broad inelastic scattering 
background in the Raman spectra [15, 44]. These aspects of the Raman spectra and 
XRPD data from Griseofulvin will be discussed below.  Milling-induced reduction in 
crystallite size to dimensions comparable to that of the Raman excitation wavelength can 
in addition give rise to excitation frequency independent Mie scattering superimposed on 
the Raman spectrum as discussed by Kiefer [45]. 
The Raman spectra of crystalline, cryomilled and amorphous griseofulvin 
obtained with 632.8 nm laser radiation using the confocal Horiba- Jobin Yvon LabRam 
micro-Raman spectrometer are shown in Figure 2.2. The observed Raman lines for the 
crystalline and amorphous samples, which are largely in agreement with the Fourier- 
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Figure 2.2 Raman spectra taken with the Horiba-Jobin Yvon LabRam micro-Raman 
spectrometer using 632.8 nm laser excitation in: (a) The 100 to 3300 cm-1 range of as-
received, micronized crystalline griseofulvin (bottom), cryomilled griseofulvin sample 
no. 2 (middle), and amorphous griseofulvin (top); and (b) The corresponding zoomed 
spectra in the 1580 to 1740 cm-1 range. 
 
transform Raman data of Feng et al [34], are listed and qualitatively assigned in Table 
2.1.The lowest frequency lines at 152, 176 and 201 cm-1 in the crystalline phase are 
assigned to mainly translational lattice modes of the griseofulvin molecule. The lattice 
mode assignments have been made qualitatively in terms of a theoretical and 
experimental study of similar modes in the Raman spectrum of the molecular crystal 
sym-triazine [46], which showed that translational modes lie at higher frequencies than 
the librational lattice modes. The calculations in ref [46] also indicate that the 
translational eigenvectors in sym-triazine are mixed to some degree with those of the 
librational modes, and this may also be the case in griseofulvin. The lines at 253 and 283 
cm-1 are tentatively assigned to second order translation-libration and molecular 
deformation-libration modes, respectively (see Table 2.1). Significant differences in 
relative peak intensities and positions can be observed when the spectra of amorphous 
and crystalline (or cryomilled) griseofulvin are compared. Most of these changes are 
evident in the low-frequency region discussed above, as well as in the lines from 500 to 
(a) (b) 
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1800 cm-1, and from 2800 to 3200 cm-1. The lines in the 560 and 640 cm-1 frequency 
regions [Figure 2.2 (b)] observed for both crystalline and cryomilled samples, become 
two broadened peaks in the amorphous sample with peaks at 565 cm-1 and 656 cm-1, 
respectively, which are attributed to C-Cl stretching modes in the molecule [47]. It was 
noticed that the formation of a strong line at 656 cm-1 strongly correlates with the 
presence of a highly disordered or amorphous phase in the griseofulvin samples as 
evident from the zoomed spectra shown in Figure 2.2 (b). It appears as a strong line in 
amorphous griseofulvin (Figure 2.2 top) and in cryomilled sample 3 [Figure 2.3 (a)] 
which is 63% amorphous as determined [34] from the DSC data shown in Figure 2.4. The 
inset in the DSC scan in Figure 2.4 (b) shows a broad two step exothermic event for 
cryomilled griseofulvin sample 3 starting at 60oC, which indicates crystallization of the 
disordered component in the sample. The DSC scan of the as-received micronized 
griseofulvin sample however shows high crystallinity with no indication of a 
crystallization transition [Figure 2.4 (a)]. However, a glass transition-like step is seen 
near 130oC for both the micronized and cryomilled samples.  
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Table 2.1 Raman Frequencies and Qualitative Mode Assignments in Crystalline and 
Amorphous Griseofulvin  
 
Crystalline     
Frequency (cm-1) 
  Intensity Amorphous   
Frequency (cm-1) 
 Intensity  Qualitative Assignment 
152 
176 
201 
253 
283 
315 
344 
 
359 
384 
435 
555 
570 
592 
635 
658 
828 
974 
1169 
1185 
1219 
1245 
1301 
1353 
1440 
 
1454 
1467 
1592 
1606 
1624 
1664 
1712 
 
2846 
2883 
2912 
2932 
2955 
2978 
3001 
3018 
3033 
3052 
3077 
3107 
3143 
 
m 
m 
m 
w 
m 
m 
w 
 
w 
m 
m 
w 
m 
w 
m 
s 
m 
m 
w 
w 
m 
m 
w 
broad,m 
w 
 
w 
m 
w 
w 
s 
m 
s 
 
w 
w 
m 
w 
m 
w 
w 
w 
w 
w 
w 
w 
w 
 
- 
- 
- 
- 
279 
310 
- 
 
- 
385 
439 
560 
- 
594 
- 
656 
- 
978 
- 
1189 
1228 
1249 
1307 
1360 
1445 
 
1464 
1476 
1596 
- 
1621 
1671 
1715 
 
2855 
2887 
2913 
- 
2855 
- 
- 
- 
3032 
- 
3078 
3108 
3138 
 
- 
- 
- 
- 
broad,w 
broad,w 
- 
 
- 
broad,w 
broad,w 
broad,w 
- 
broad,w 
- 
s 
- 
m 
- 
broad,w 
broad,w 
broad,w 
broad,w 
sharp,s 
broad,w 
 
broad,w 
broad,w 
broad,w 
- 
broad,s 
broad,w 
broad,s 
 
broad,w 
broad,w 
broad,w 
- 
broad,m 
- 
- 
- 
broad,w 
- 
broad,w 
broad,w 
broad,w 
 
 Translational lattice mode 
 Translational lattice mode 
 Translational lattice mode 
 Translation+libration 
 Ring deformation + libration 
 Out-of-plane ring deformation 
 Out-of-plane ring deformation 
 
 C-Cl deformation 
 C-Cl deformation 
 C-Cl deformation 
 Ring stretching 
 C-Cl stretching 
 C-Cl stretching 
 C-Cl stretching, ring deformation 
 C-Cl stretching 
 Cyclohexanone ring stretch 
 Benzene ring asymmetric stretch 
 CH-rocking 
 Ring vibration, -C-O-C stretch 
 -CH in-plane deformation 
 -CH in-plane deformation 
 -CH in-phase twist 
 -CH3 and -CH2 deformations 
 -Asym CH3 deformation 
 
 -Asym CH3 deformation 
 -Asym CH3 deformation 
 C=O stretch 
 C=O stretch 
 C=O mixed with C=C stretch 
 C=C stretch in cyclohexanone 
 C=O stretch in benzofuran 
  
 -CH symmetric stretch 
 -CH3 symmetrical stretch 
 -CH2 symmetrical stretch 
 -CH3 asymmetrical stretch 
 -CH2 asymmetrical stretch 
 -CH3 symmetrical stretch 
 -CH3 symmetrical stretch 
 -CH3 symmetrical stretch 
 Aromatic =CH stretch 
 -CH3 asymmetrical stretch 
 -CH3 asymmetrical stretch 
 -CH3 asymmetrical stretch 
 -CH3 asymmetrical stretch 
 
s – small, m – medium, w – week 
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Another feature in the Raman spectra is the disappearance of the 828 cm-1 line, attributed 
to the cyclohexanone ring stretching vibration, with decrease in crystallinity of the 
sample. The 1550 to 1800 cm-1 spectral range corresponding to the C=O stretching 
vibrational frequencies of the benzofuran ring [30] displays a characteristic triplet of lines 
which undergoes frequency shift, broadening, and decrease in relative peak intensity in 
the amorphous phase. For crystalline and cryomilled samples, the first peak of the triplet 
splits into three additional peaks at 1592, 1602, and 1624 cm-1 respectively [Figure 2.2 
(b)], resulting probably from the interaction between the two C=O stretching modes and 
partial conjugation in the neighboring cyclohexanone ring where the π-electron system is 
delocalized [47, 48]. Conjugation in this part of the molecule is also significantly 
distorted due to the presence of a 2-methoxy group in the cis-conformation relative to the 
double bond on the cyclohexanone ring [49]. In the amorphous form, this splitting no 
longer exists and only two broader peaks, both shifted to higher frequencies, are 
observed.  
  (a)                                           (b)                                             (c)      
 
 
 
 
 
 
Figure 2.3 Raman spectra recorded with 785 nm excitation using the Mesophotonics SE 
1000 spectrometer in the 100 to 2400 cm-1 range of: (a) As-received micronized 
griseofulvin sample (bottom) and cryomilled griseofulvin sample no. 3 (top), (b) 
Cryomilled griseofulvin sample no. 2,  and (c) Cryomilled griseofulvin sample no 1. The 
boxed spectral region around 700 cm-1 on each panel are expanded and shown as insets 
on the top right of each panel.  
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Furthermore, examination of the C-H stretching region in the 2800 to 3150 cm-1 range 
shows substantial loss in intensities over several peaks in the amorphous phase due to 
changes in inter-molecular hydrogen bonding interactions. 
(a)                                                            (b) 
 
 
 
 
 
 
 
 
Figure 2.4 Differential scanning calorimeter scans for: (a) As-received micronized 
griseofulvin, and (b) Cryomilled griseofulvin sample 3. An expansion of the boxed-in 
region between 60 and 110°C is shown in the inset.  
 
2.4.3 Inelastic Raman Scattering Background 
A key feature in the Raman spectra is a superimposed broad, excitation energy-
independent inelastic scattering background observed both in cryomilled and amorphous 
griseofulvin samples. This broad scattering was observed using two different Raman 
spectrometers operating with 632 and 785 nm laser sources as shown in Figure 2.2 and 
2.3, respectively. As discussed below, the observed background does not correspond to 
fluoresence spectra taken from the same samples. This strong background in the Raman 
spectra is assigned to lattice disorder induced by cryomilling [34, 36]. In addition to this, 
particle size reduction to the range of the exciting laser wavelength will concomitantly 
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give rise to Mie scattering in the milled samples [45]. In the largely amorphous samples 
however the background scattering in the Raman spectra is primarily associated with 
lattice disorder. 
The inelastic scattering background for cryomilled griseofulvin was fitted to two 
peaks using a Lorentzian function as shown in Figure 2.5 (a). The number of peaks 
included in the fitting was determined by the lowest residual value obtained during 
fitting. The two-peak fit suggests the existence of light scattering at two correlation 
lengths – the narrower one associated probably with Mie scattering resonances discussed 
earlier and the broader one to amorphous-like disorder in the sample. This is consistent 
with the fact that only a single peak fit is obtained for the amorphous sample in Figure 
2.5 (b).  
(a)                                                             (b) 
 
 
 
 
 
 
 
 
Figure 2.5 Fit of the inelastic Raman scattering background using a Lorentzian function. 
Panel (a) shows the fit for cryomilled griseofulvin sample 2, and panel (b) shows the fit 
for the amorphous griseofulvin sample.  
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To obtain further insight into cryomilling-induced disorder and Mie scattering, the 
effect on the Raman spectra of humidity and laser annealing of the cryomilled samples, 
was studied as described and interpreted below:    
(a) Effect of exposure to high humidity  
Humidity treatment is known to result in crystal growth by Oswald ripening. Griseofulvin 
is highly insoluble in water and exposure to water vapor in a humid atmosphere can 
modify its surface properties similar to water acting as a plasticizer [50]. The humidity 
treatment experiment conducted on cryomilled griseofulvin sample 1 showed a reduction 
in background intensity as observed by a consistent decrease in the inelastic scattering 
background compared with a minimal change in the as-received reference griseofulvin 
sample [Figure 2.6 (a)]. The cryomilled sample showed a reduction in background  
(a)                                                            (b) 
 
 
 
 
 
 
 
Figure 2.6 Comparison of the effect of annealing treatments on the Raman spectra of 
cryomilled griseofulvin after: (a) Humidity exposure taken with the Mesophotonics SE 
1000 Raman spectrometer and 785 nm excitation, and (b) 30 minutes of 632 nm laser 
exposure taken with the Horiba-Jobin-Yvon Raman spectrometer. In each panel, the top 
spectrum is that of cryomilled griseofulvin sample 1, the middle spectrum is that of same 
cryomilled sample after annealing treatment (see text for details), and the bottom 
spectrum is that of as-received, micronized griseofulvin from Sigma Aldrich. 
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intensity at the location of the line at 656 cm-1 from the original baseline-corrected 
intensity of 41,709 counts/seconds to a value of 30,038 counts/seconds. This represented 
a 28% decrease in background intensity after seven days of exposure to high humidity. 
The background intensity remained at approximately 30,750 counts/seconds after seven 
days of exposure to high humidity, suggesting that most of the Oswald ripening occurred 
near the initial exposure. The baseline corrected background intensity of the reference 
sample remained essentially constant during this period. The observed decrease in Raman 
background intensity is also consistent with the assignment of this signal to crystallite 
size related disorder and Mie scattering rather than fluorescence.   
(b) Effect of laser exposure  
Laser annealing has been widely used to rapidly induce crystal nucleation in 
amorphous silicon films [51-53]. In the case of organic materials, there are few reports of 
successfully annealing crystal imperfections by inducing preferred molecular 
arrangements [54-56]. In this study on cryomilled griseofulvin sample 1 using focused 
632.8 nm laser irradiation, the most pronounced annealing occurred after only 30 minutes 
of exposure as evident from Figure 2.6 (b). Background intensity was reduced for the 
peak at 656 cm-1 from the original value of 28,000 to 13,000 counts/seconds. This is a 
reduction of 54%, which can be attributed to annealing of defects and disorder due to 
growth in crystallite size. The relative intensity of the Raman signal remained constant 
with only minor deviation throughout the process indicating that no sample degradation 
was occurring. As pointed out in the Introduction, laser annealing applies heat locally and 
thus forms a solid-liquid interfacial strain region which is not formed in bulk thermal 
annealing. Laser annealing would therefore rapidly remove defects or disorder, and by 
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using rastering and broadening of the laser beam would have potential pharmaceutical 
application as a processing procedure. 
2.4.4 Fluorescence Spectroscopy 
Defect states can exist in the band gap of insulating and semiconducting solids [57] which 
give rise to fluorescence emission in molecular crystals with localized defects. As 
discussed above, the Raman spectra from cryomilled griseofulvin is associated with 
disorder and Mie scattering rather than localized defects. To further confirm this 
interpretation, solid state fluorescence spectra of cryomilled griseofulvin were measured 
and compared with the spectrum from as-received, micronized griseofulvin.  The solvent 
corrected UV-visible spectrum of a griseofulvin solution in acetone showed a strong 
absorption band near 300 nm. This wavelength was therefore used to excite the 
fluorescence emission spectra from both the as-received and cryomilled samples of 
griseofulvin. The fluorescence spectra do show that as-received griseofulvin emits in the 
mid-infrared range, but the emission is partially quenched by cryomilling. Moreover, 
there is a lack of correspondence between the fluorescence and the background Raman 
spectra. This is evident from the combined plots of the Raman and fluorescence 
intensities versus wavelength shown in Figure 2.7.   
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(a)                                                                 (b) 
 
Figure 2.7 Raman (—) and fluorescence (---) spectral intensities plotted versus 
wavelengths for cryomilled griseofulvin sample 1. Panel (a) shows the combined plot of 
the Raman λex = 632 nm spectrum taken using the confocal Horiba Jobin Yvon LabRam 
micro-Raman spectrometer and fluorescence spectrum taken with λex = 300 nm. Panel (b) 
shows the combined plot of the Raman λex = 785 nm taken using the Mesophotonics 
SE1000 Raman spectrometer and fluorescence spectrum taken with λex = 300 nm. 
 
2.4.5 Powder X-Ray Diffraction (XRPD) 
Wide-angle XRPD diffraction and scattering data obtained using CuKα radiation are 
shown in Figure 2.8 (a) for the as-received micronized and cryomilled griseofulvin 
sample 3, respectively. A broad scattering background is observed superimposed on the 
diffraction peaks in the cryomilled sample, but except for an increase in scattering at 
small angles, it is clearly absent in the as-received sample. The broad scattering in the 
cryomilled sample can be deconvoluted into two Gaussian components as shown in 
Figure 2.8 (b), pointing to the presence of disorder in the sample at two correlation 
lengths. The XRPD data from a micronized sample has also been obtained using a 
Synchroton X-ray source as a function of increasing temperature to the amorphous phase 
through the melting point at 218oC, as shown in Figure 2.8 (c). As evident from the 
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figure, a two-peak small-angle background is seen in the crystalline phase which persists 
into the amorphous phase where the diffraction lines disappear. 
(a)                                                                  (b) 
 
 
 
 
 
 
      (c)   
 
 
 
 
 
 
Figure 2.8 (a) Wide-angle X-ray powder diffraction patterns of cryomilled sample 3 
(bottom) and as-received micronized griseofulvin (top) obtained using CuKα radiation,  
λ =1.5406 Å; (b) Shows Gaussian function fits to the X-ray scattering background in the 
wide-angle diffraction pattern of cryomilled griseofulvin sample 3 shown in panel (a); 
and (c) Shows a sequence of plots of small-angle Synchrotron (1.09 Å) X-ray powder 
diffraction patterns of as-received micronized griseofulvin as a function of temperature to 
above the melting point at 218oC. The diffraction data in panels (a) and (b) have been 
offset for easy viewing.   
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2.5 Conclusions 
A broad scattering background which can be deconvoluted into two components is 
observed in the Raman spectra of cryomilled griseofulvin relative to the spectra of 
reference samples of as-received, micronized griseofulvin. Comparison of the Raman 
with fluorescence spectra has ruled out fluorescence from molecular defects and 
impurities as the cause of the background scattering. It was concluded that structural 
disorder and associated Mie scattering centers on nanosized crystals are produced on 
cryomilling and contributes to the inelastic scattering background in the Raman spectra. 
Similar but more intense background scattering, which can be fitted to a single 
Lorentzian function, is seen in thermally produced amorphous griseofulvin. Wide-angle 
XRPD data on cryomilled griseofulvin shows a diffuse scattering component which can 
be fitted to two Gaussian functions due to disorder at two correlation lengths. Disorder at 
longer lengths has been probed by small-angle XRPD using Synchrotron radiation on 
micronized griseofulvin as a function of temperature from the crystalline to the 
amorphous phase. Disorder at two levels, which persists without much change into the 
amorphous phase, is also evident in this range.  
Although it is widely known that Raman spectroscopy provides important 
information regarding the presence of crystalline and amorphous forms based particularly 
on the half-widths of Raman lines [15, 43], the results presented here show that additional 
effects like the onset of diffuse scattering superimposed on the Raman lines in organic 
solids can be used to assess the degree of disorder introduced as a result of mechanical 
processing.  This will therefore expand the application of Raman spectroscopy to the 
characterization and quality control of active organic pharmaceuticals.
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                                                         CHAPTER 3 
POLYMORPH CHARACTERIZATION AND STABILIZATION IN PROCESSED 
AND UNPROCESSED ACETAMINOPHEN POWDERS  
 
3.1 Objective 
The objective of this chapter is to discuss and understand a novel approach developed 
here to stabilize the metastable type II acetaminophen (APAP) polymorph. A new 
interface of the stable type I APAP particles was created by micronization of the 
crystallites or by dry-coating with nanosized silica. These micronized and coated particles 
when converted to type II showed extensive long-term stability of the metastable type II 
phase. Type II APAP is commercially important because it is known to have improved 
tabletting properties. In previous studies, polymers have been used [58, 59]  to formulate 
a more stable type II APAP phase. The newly developed type II stabilization discussed 
here can therefore have important implications in pharmaceutics.  
Raman spectroscopy together with analysis by complementary techniques, such as 
X-ray powder diffraction (XRPD), and conventional and intrinsic dissolution were used 
to characterize the stabilized type II phase. The XRPD experiments also confirmed 
Raman data showing that no structural change to type II occurs when type I was initially 
micronized or dry-coated with nanosilica. Raman spectroscopy also showed the onset of 
a time-dependent background scattering in stabilized type II APAP. This scattering is 
similar to that seen in cryomilled griseofulvin [3] and is likely to be associated with the 
further growth of small amounts of initially formed nanosized nuclei of the stable type I 
polymorph detectable by XRPD, and defects associated with this growth process. It is 
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expected that further optimization of the stabilization process would make the type II 
phase indefinitely stable.  
Topics that follow below are: Polymorphism in APAP, experimental methods 
used, interpretation of the Raman spectra of APAP in its different phases, Raman spectral 
monitoring as a function of time of the stabilized type II APAP, complementary 
characterization of the type II phase by other techniques, and conclusions. In addition, an 
oriented single crystal Raman study of type I APAP and a study of the spectra as a 
function of temperature were performed. The latter is important in understanding thermal 
changes that occur during milling processes employed to reduce particle size to improve 
drug dissolution for pharmaceutical applications. The results and discussion of the single 
crystal data are included in Appendix A at the end of this thesis. A corresponding 
uniaxial pressure study simulating another component of the milling process is planned in 
the future.  
 
3.2 Polymorphism in Acetaminophen 
Acetaminophen (APAP), one of the model drugs under investigation in this study is a 
widely used analgesic drug and it is an excellent example of a polymorphic system as it is 
known to exist in three forms with different crystalline packing, and a disordered, 
amorphous form. Type I APAP is a monoclinic crystal, type II is orthorhombic, whereas 
type III is too unstable for its structure to be determined. Type I (commercially available) 
is the most stable at room temperature, but it has poor binding and densification 
properties [60]. Both types I and II phases can be grown out of the molten state of APAP 
crystals. The unstable type III can also be grown from the melt but only between two 
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surfaces. From the commercial point of view, it is desirable to stabilize the metastable 
type II due to its enhanced compression behavior and higher intrinsic dissolution rate [61, 
62] compared to phase I. The compression properties of type I and II polymorphs relate 
to different molecular packing in the two forms. The molecules form puckered layers in 
the type I polymorph and flat sheets or layers in type II, as evident from Figures 3.1 (a) 
and (b), respectively. Van der Waals intermolecular bonding occurs between the sheets 
and stronger intermolecular hydrogen bonding exists among the molecules in the sheets. 
As shown in Figure 3.2 (b), two types of hydrogen bonding, NH∙∙∙O and OH∙∙∙O, which 
differ significantly in their corresponding bond lengths - 2.91 Å and 2.65Å in type I and 
2.97Å and 2.72Å in type II phases, are observed in APAP crystals [42]. The shorter 
(stronger) intra-layer hydrogen bonding in type I results in its higher melting point and 
greater thermodynamic stability relative to the type II phase [63, 64]. Another interesting 
feature is the higher plastic deformability of type II relative to the type I phase, which is 
consistent with its flat layered architecture in contrast to the puckered architecture of the 
molecules in the type I phase.  
(a)                                                                     (b) 
 
Figure 3.1 Unit cells of acetaminophen in: (a) Type I, and (b) Type II phases. 
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(a)                                                     (b)                                                        
 
 
 
 
 
 
 
 
Figure 3.2 (a) Molecular structure of acetaminophen, and (b) Type A and type B 
hydrogen bonding between acetaminophen molecules in type I and type II acetaminophen 
phases [42]. 
 
The relative orientation of layers of acetaminophen molecules in each structural 
type relates to compaction properties and behavior of each phase under pressure. The 
more planar orientation of the sheets in type II is attributed to its well-developed slip 
system and higher plastic deformability [65].  Type I does not deform plastically since 
the relative orientation of the molecular sheets resembles a zig-zag or puckered 
arrangement. As a result, type I breaks by brittle fracture and requires binding agents 
during manufacture to ensure that the tablets remain intact after compression.  
Based on structural orientations, APAP can be classified as an unstable crystal 
compared to the relatively stable griseofulvin which shows no polymorphic transitions 
except for the amorphous state. It is of importance to understand how process design can 
potentially benefit from polymorphic transitions of a crystal [66]. A large number of 
publications have been devoted to APAP behavior during pharmaceutical processing [59-
NH
O
OH
CH3
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61, 67, 68] since its polymorphism is known to influence mechanical properties and 
dissolution rate. In particular, the more elastic but metastable type II APAP can be 
compressed directly but it transforms to the stable type I form within days. Several 
techniques have been employed to stabilize type I APAP by using stabilization agents, 
such a gelatin, polyvinylpyrrolidone (PVP) or starch [69]. Di Martino prepared the pure 
orthorhombic type II phase of APAP for direct compression with fairly good results and 
stability up to 11 months [67]. In the present study, two methods are used to increase the 
stability of type II APAP. In the first method, metastable type II APAP is produced from 
the melt using micronized type I APAP. In the second method, unmicronized type I 
APAP is dry-coated with nano-silica and then type II APAP is generated from it.  
 
3.3 Experimental Methods and Details 
In this section the sources and preparation of the following APAP samples and 
characterization methods used are described:  
APAP I – Purchased form AnMar International Ltd (Bridgeport, CT), and used as-
received. 
MAPAP (micronized APAP) I – Purchased form AnMar International Ltd (Bridgeport, 
CT), and used as-received. 
SiO2 APAP I – Hydrophilic Nano-silica was purchased from Cabot Corp (U.S.A). SEM 
characterization showed the particle size of nano-silica to be about 40 nm. APAP I was 
coated with 1% (w/w) nano-silica using the dry-coating technique described below.  
Raman spectroscopy confirmed that no chemical and structural changes resulted from 
nano-silica dry coating.  
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Dry coating: The dry particle coating used the technique of magnetic assisted impaction 
coating (MAIC), to disperse the nano-sized guest silica particles onto the surface of the 
primary host particles. The dry particle method is discussed in detail in reference [70] and 
was performed by Laila Jallo in Prof. Rajesh Dave’s group at NJIT. 
APAP II – Normal type II APAP was generated from as-received crystalline type I 
APAP. A few milligrams of APAP I was placed on a glass slide and melted at 190°C. To 
obtain the type II phase, the hot melt was rapidly cooled in a freezer resulting in a thin 
film of sample on the glass slide.  
MAPAP (micronized APAP) II – Type II APAP was generated from MAPAP I 
following the same procedure as for APAP II. 
SiO2 APAP II – Type II APAP was generated from SiO2 APAP I following the same 
procedure as for APAP II. 
All samples prepared in this manner were stored in ambient conditions.  
The formation of the orthorhombic phase II in all fabricated samples of acetaminophen, 
in particular APAP II, MAPAP II, and SiO2 APAP II in thin films or crushed powders 
(for dissolution studies) were confirmed by Raman spectroscopy.  
Conventional Dissolution Rate (CDR): Dissolution analysis was performed using a 
basket dissolution tester Distek 2100A USP apparatus 1 (North Brunswick, NJ). Samples 
were tested according to the USP29-NF24 monogram for acetaminophen capsules. The 
dissolution profile was obtained as per specified monogram conditions using a 
dissolution tank with six dissolution vessels, 900 ml each, equipped with rotating baskets 
with samples. Approximately 50 mg of sample was enclosed in a gelatin capsule as 
shown in Figure 3.3 (a) and placed in each of the dissolution baskets, immersed into the 
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vessel with DI water at 37oC, and rotated at a constant speed of 50 rpm.  The water bath 
temperature was constant during the experiment.    
Aliquots of 5 ml were removed at time interval, t = 0, 5, 10, 15, 20, 25 and 30 
minutes and analyzed using a UV-vis spectrophotometer (for instrument details see 
Chapter 2). A calibration curve was generated by a set of freshly prepared standard 
solutions of 0.005 mg/ml, 0.010 mg/ml, 0.025 mg/ml, 0.050 mg/ml, and 0.060 mg/ml 
concentrations of as-received type I acetaminophen in water. All samples were run in 
triplicate to create a dissolution profile and reliable data set. Dissolution analyses were 
performed for the following types of acetaminophen: APAP I, APAPA II, MAPAP II, 
and SiO2 APAP II.    
Intrinsic Dissolution Rate (IDR): A Venkel, VK 7000 dissolution apparatus equipped 
with compacted and rotating disk was employed, as shown in Figure 3.3 (b) to perform  
 
(a)                                          (b) 
 
 
 
 
 
 
 
Figure 3.3 (a) APAP capsule used for conventional dissolution analysis, and (b) 
Schematic of an intrinsic dissolution apparatus consisting of a steel plunger and a die, and 
a rotating shaft with attached sample holder immersed in the dissolution vessel [71].    
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intrinsic dissolution on four batches of acetaminophen: APAP I, APAP II, MAPAP II, 
and SiO2 APAP II.  Sampling and experimental conditions were the same as described 
above for the conventional dissolution rate study. A typical IDR apparatus consists of a 
steel plunger and die, and a stainless steel sample holder for direct compaction as shown 
in Figure 3.3 (b). Approximately 40 mg powder sample of APAP I was directly 
compressed using a hydraulic press Carver Press, Model C, applying a pressure of 3 kN 
for 30 seconds to form a 0.6 mm diameter disc inside the sample holder. The same 
procedure was repeated for the remaining batches, where for each batch analysis was 
performed in triplicate. The sample holder was attached to the rotating shaft and 
immersed into the dissolution bath. Prior to analysis, the air pockets formed at the bottom 
of the sample holder during immersion were carefully removed. Using a Cary 50 UV-vis 
spectrometer, and a set of standards of the same concentrations as above, the mass of 
dissolved acetaminophen was calculated after correcting for the change in volume and 
including the disk area. The IDR analysis was performed in collaboration with Dr Shirlyn 
Chen’s group at Boehringer-Ingelheim, Ridgefield, CT. 
For both types of dissolution testing, thin films were gently crushed to generate 
powders which were then confirmed to be type II APAP by Raman spectroscopy. 
For brief descriptions of Raman spectroscopy, small and wide angle XRD, and SEM 
instrumentation, see Chapter 2.  
 
3.4 Raman Spectra of Acetaminophen Polymorphs  
After X-ray diffraction, Raman scattering is one of the most widely used methods 
employed to study polymorphism and structural transformations because of its high 
sensitivity to crystalline structure. In the case of acetaminophen, three different 
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arrangements of the molecules in the crystalline state are known besides the disordered 
amorphous phase obtained from the melt. Among the three phases only type I is known to 
be thermodynamically stable and is the form that is used in pharmaceutical applications. 
However, it was discovered in this work that composite formation due to dry coating with 
nanoscale silica and surface modification by top-down micronization provide long-term 
stability to type II APAP possibly via the formation of a new interface which stabilizes 
the molecular architecture of this normally metastable phase. As previously discussed in 
Chapters 1 and 2, Raman spectroscopy is particularly suited to understand evolving 
structural behavior and is therefore used here as the primary tool to monitor the changes 
in type II APAP as a function of elapsed time. Raman spectra shown in Figure 3.4, 
together with the frequencies and their possible assignments in Table 3.1, for all four 
types of APAP have been measured down to 100 cm-1 and are in essential agreement with 
the data previously reported by both Szelagiewicz et al [72] and Kauffman et al [73].  
Raman lines below 200 cm-1, studied for the first time to the best of our knowledge, are 
assigned to inter-molecular or lattice modes which are particularly sensitive to the 
crystalline arrangements and clearly show differences between the four types of APAP 
phases. For type I, the lowest frequency lines at 136 cm-1 and 155 cm-1 are assigned to 
largely translational motions of the acetaminophen molecule, similar to observations in 
griseofulvin discussed in Chapter 2. Both of these lines shift to lower frequencies (127 
cm-1 and 145 cm-1, respectively) in type II APAP.  In the amorphous phase, long-range 
crystalline order is lost and the molecules are randomly oriented.  The low frequency 
Raman lines persist in the amorphous phase due to some short-range order but are 
substantially broadened due to long-range disorder. The low frequency Raman spectrum 
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of type III APAP is interesting. The translational mode features are not evident and 
appear to be embedded in a broad scattering background similar to that seen in 
cryomilled griseofulvin (see Chapter 2). The observation of a strong scattering 
background suggests that the type III structure is highly defected and probably stabilized 
by these defects.  
 Raman lines attributed to intra-molecular vibrational modes are observed at 
frequencies above 200 cm-1 for the different polymorphs and the amorphous phase as 
shown in Figure 3.4 (a). Changes in these lines occur in the different phases due to 
changes in local potentials and are more subtle than those for the Raman features 
assigned to inter-molecular or lattice vibrations discussed above. More detailed views of 
the Raman features in the spectral regions between 1200 to 1280 cm-1 and between 1500 
to 1650 cm-1 are indicated in Figures 3.4 (b) and (c), respectively. The Raman lines in the 
1200 to 1260 cm-1 frequency region correspond to C-N, C-H, and phenyl ring vibrations 
[47]. The characteristic C-N stretching Raman line at 1237 cm-1 for type I APAP 
develops into two well resolved peaks at 1221 cm-1 and 1245 cm-1 in type II APAP due to 
change in local symmetry.  Further, there is substantial broadening of the 1237 cm-1 line 
in the amorphous phase with almost no frequency shift relative to that of the line in the 
type I phase. In the type III phase this line broadens and upshifts by 6 cm-1 to 1243 cm-1 
indicating some strengthening of the C-N bond.  
 Additionally, other changes in the intra-molecular vibrational lines are observed 
in the Raman spectra as a function of crystalline polymorph or amorphous phase in the 
1500 to 1650 cm-1 frequency region shown in Figure 3.4 (c). Here, changes occur in the 
relative intensities and peak positions of Raman lines that are attributed to –N-H 
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deformation and C=O stretching modes. The strongest lines for type I APAP are seen at 
1611 cm-1 and 1649 cm-1 and are assigned to –N-H deformation and C=O stretching 
modes, respectively. In the amorphous phase both of these lines upshift by 9 cm-1 
together with significant broadening as well as increase and decrease in relative peak 
intensity, respectively. These changes are most likely associated with the absence of 
ordered intermolecular interaction in the amorphous phase and type A and B hydrogen 
bonding explained above.  The upshift in the peak positions indicate that the force 
constants for N-H deformation and C=O stretching increase probably because inter-
molecular interactions are disrupted in the amorphous phase. In case of type III APAP 
intermolecular interactions persist, and the line at 1611 cm-1 upshifts by 3 cm-1 whereas 
the line at 1649 cm-1 downshifts by 2 cm-1 due to changes in the local inter-molecular 
potentials. For type II, the type I APAP line at1611 cm-1 splits into two peaks at 1578  
cm-1 and 1623 cm-1 indicating substantial changes in the hydrogen bonding interactions.   
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Figure 3.4 Raman spectra of acetaminophen polymorphs and its amorphous phase 
prepared directly from its stable type I phase in the spectral regions: (a) 100 to 3500 cm-1, 
(b) 1200 to 1260 cm-1, and (c) 1500 to 1650 cm-1. Color coding: Green (amorphous), blue 
(type I), red (type II) and black (type III). 
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Table 3.1 Raman Frequencies and Qualitative Mode Assignments of Acetaminophen in 
its Three Polymorphic and Amorphous Phases 
 
Type I 
(cm-1) 
Type II 
(cm-1) 
Type III 
(cm-1) 
Amorphous 
(cm-1) 
Qualitative Assignments 
135 127 - -  
155 145 146 143 Translational lattice modes 
- 172 183 -  
205 208 210 -  
218 - - 215  
     
326 330 330 330 Out-of-plane ring deformation 
388 388 388 388  
462 452 457 458 Out-of-plane ring deformation 
501 5050 505 508 Out-of-plane ring deformation 
649 649 646 650 In-plane ring deformation 
796 796 799 800 Phenyl ring stretch [74] 
839 - - 831 C-H out-of-plane bend 
856 856 862 864 Phenyl ring C-H stretching 
1169 1169 1172 1174 C-H in-plane bend 
- 1221 - - C-C stretch carbon phenyl ring 
1237 - - 1238 C-N stretch 
- 1245 1242 -  
1278 1278 1278 1280 O-H and C-O combination, (ar) C-N 
stretch 
1324 1326 1321 1328 C-H bend 
1371 1376 1374 1378 -CH3 umbrella mode 
1559 - 1562 1562 -H-N-C=O stretch [74] 
- 1578 - -  
1611 1609 1614 1620 -N-H deformation [74] 
- 1623 -     -      
1649 1649 1647 1658 C=O stretch [74] 
     
2937 2940 2928 2938 -CH3 symmetric stretch 
3016 3018 3009 3018 -CH3 symmetric stretch 
- -      3045 -      -CH3 symmetric stretch 
3058 3069 -     -      -CH3 symmetric stretch 
- -      3067 -     -CH3 asymmetric stretch 
3072 -      -     3072 -CH3 asymmetric stretch 
3083 3083 3095 -      -CH asymmetric stretch, phenyl ring 
- -     3095 -    
3110 3111 -  3107 -CH asymmetric stretch, phenyl ring 
3163 3166 3159 3155 O-H stretch 
3326 3328 3329 -    N-H stretch 
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3.5  Monitoring the Stability of the APAP II Polymorph by Raman Spectroscopy 
 
As noted above, new interfaces in type I APAP were created by micronizing and dry 
coating with nanosized silica to form a stabilized type II APAP. In this section results on 
monitoring the stabilized phase by Raman spectroscopy as a function of time are 
discussed. 
The spectra over a period of months for type II APAP prepared from micronized 
and dry-coated type I APAP are displayed in Figure 3.5 (a) and (b) show that the Raman 
spectral features of type II APAP discussed above remain unchanged. No molecular scale 
events appear to take place based on the frequencies, intensities and linewidths of the 
Raman lines. However, a broad scattering background superimposed on the Raman 
spectra similar to that seen in griseofulvin [3] is observed. The intensity of this scattering 
increases up to 180 days for the sample from micronized APAP and then starts to 
decrease as shown in the inset in Figure 3.5 (a). The scattering intensity for the sample 
from dry-coated APAP shown as an inset in Figure 3.5 (b) appears to saturate already 
after 90 days, but has been monitored so far for only 150 days.   
One interpretation of the background scattering is that it is associated with 
scattering from defects associated with growing nanocrystallites of the stable type I phase 
in the matrix of the type II phase, albeit initially form in quantities that are too small to be 
observed in the Raman spectra but detectable by XRPD as discussed below. With time 
these defects anneal out as indicated by reduction or saturation in the background 
scattering intensity. Further studies will continue in the type II sample from nanocoated 
APAP to see if a reduction in background scattering intensity occurs there as well.  
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Although a quantitative model needs to be developed, it can be conjectured that 
the stabilization of the type II phase by dry coating and micronization occurs through 
local potential energy minima of the conformational space at the interface between APAP 
and nanosilica, and between surface and bulk APAP, respectively. As an interesting 
observation, it was noticed throughout multiple sample preparations that the formation of 
the metastable type II APAP phase appears to begin at the sample surface. In dry coated 
and micronized APAP, stabilization can occur via immobilization of the type II structure 
at the coating-APAP and surface-bulk interface followed by rapid crystallization of this 
phase throughout the film formed from the melt. Further improvement in phase II 
stabilization is therefore possible via APAP improved dry coating and APAP particle size 
reduction.   
(a)                                                                (b) 
 
 
 
 
 
 
 
 
Figure 3.5 Raman spectra showing the stabilization of type II acetaminophen as a 
function of time for samples prepared by melt formation from: (a) Micronized type I 
APAP I, and (b) Nano-silica dry-coated type I APAP. 
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3.6 Characterization of the APAP II Polymorph by SEM, XRPD and Dissolution 
Measurements  
 
3.6.1 Scanning Electron Microscopy (SEM) 
The SEM studies were carried out to image the physical features of the samples since 
various sample types with different morphologies were employed: as-received powders, 
fabricated thin films, and powders from crushed films. The orthorhombic and monoclinic 
phase II and phase I polymorphs can be easily recognized due to differences in their 
corresponding crystal habit, especially when a high magnification tool, such as SEM is 
used. Figure 3.6 (a), (b), and (c)  show representative images of as-received crystalline 
APAP I, as-received micronized APAP I, and nano-silica coated APAP I, respectively. 
Figures 3.7, 3.8, and 3.9 show SEM images of APAP II, MAPAP II, and SiO2 APAP II, 
fabricated as thin films. Interestingly, APAP II in Figure 3.7 showed a large number of 
air pockets formed during film solidification which explains the fact that substantial 
absorption of water vapor through the air pockets accelerates the transition to the stable 
APAP type I. Air pockets were not observed for MAPAPA II and SiO2 APAP II samples. 
Crystal habits of both type I APAP (monoclinic) and type II APAP (orthorhombic) were 
observed on the surface of nanocoated SiO2 APAP II films shown in Figure 3.9 (indicated 
by arrows) consistent with XRPD results discussed below.  
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(a)                                       (b)                                       (c) 
Figure 3.6 SEM images of (a) As-received crystalline APAP I, (b) As-received 
micronized APAP I, and (c) Nano-silica dry coated APAP I.  
 
 
Figure 3.7 SEM images of APAP II sample fabricated as a thin film. Formed air pockets 
are indicated by arrows. Images are shown in order of increasing magnification. 
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Type I 
Type II 
 
 
 
 
 
 
Figure 3.8 SEM images of MAPAP II sample fabricated as a thin film. Images are shown 
in order of increasing magnification.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9 SEM images of SiO2 APAP II sample fabricated as a thin film. Presence of 
monoclinic and orthorhombic crystals indicated by arrows.    
 
 
3.6.2 X-Ray Powder Diffraction (XRPD) 
Wide-angle XRPD diffraction and scattering data obtained using CuKα radiation are 
shown in Figure 3.10 (a) for as-received MAPAP I and MAPAP II and Figure 3.10 (b) 
for dry-coated SiO2-APAP type I and fabricated SiO2-APAP type II samples, 
respectively. XRPD data for MAPAP I and II, and SiO2-APAP I, agree with that 
published by Welton et al [75]. By contrast, the XRPD pattern for type II SiO2-APAP is 
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different from that reported in the literature. After careful evaluation of the diffraction 
patterns and SEM images it was concluded that the XRPD pattern resulted from the 
presence of small quantities of type I (not detected by Raman) in the primarily type II 
phase sample, consistent with the SEM images discussed in section 3.6.1 above.   
(a)                                                  (b) 
 
 
 
 
 
 
 
 
 
Figure 3.10 Wide-angle X-ray powder diffraction patterns of acetaminophen samples 
obtained using CuKα radiation, λ =1.5406 Å, (a) MAPAP I and MAPAP II and (b) SiO2 
APAP I and SiO2 APAP II. 
 
3.6.3 Dissolution Profiles  
By definition, “dissolution is defined as the process by which solid substances enters a 
solvent to yield a solution” [71]. Conventional dissolution rate (CDR) analysis was 
carried out to test the behavior of the stabilized type II APAP samples. Since all samples 
used for CDR were enclosed in gelatin capsules, the initial physical state of the sample, 
such as micronized size or surface coating with nano-silica, were not accounted for.  
Figure 3.11 (a) compares the dissolution profiles of types I and II APAP with stabilized 
type II APAP samples via conventional dissolution rate analysis. It can be seen that 
63 
 
 
almost complete mass release is seen in type I APAP within the first 10 minutes of 
analysis; this was followed by type II APAP. The two modified acetaminophen type II 
samples showed no improvement in dissolution rate, in fact it took almost three times as 
long, compared to APAP type I, for these samples to completely dissolve.   
 Since modified APAP type II samples are generated from micronized and silica-
nanocoated APAP I, potential variations in the surface area are created which affect the 
conventional dissolution rate.  Intrinsic dissolution rate (IDR) is characteristic of the 
initial physical state of the sample. IDR is described by the equation 3.1 which is also 
referred to as the Noyes-Withney equation [76]: 
 
 CCk
Adt
dmJ s  1
                                    (3.1) 
 
where, 
dm/dt – Rate of increase of the mass of solute released per unit time t 
k – Mass transfer coefficient 
A – Surface area of the sample 
Cs – Intrinsic solubility at sample surface 
C – Concentration of solute dissolved at time t. 
Equation 3.1 can be further reduced to equation 3.2 since for sink conditions Cs >>C,  
 
 sCkAdt
dmJ  1
                                        (3.2)
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Equation 3.2 indicates that the rate of dissolution may vary if the surface area of 
the solid is altered. There are many known surface modification techniques, such as 
particle size (micronization), crystalline form of a solid (polymorphs), or coating that can 
act as a barrier to the dissolution rate. Since both micronization and surface coating were 
employed here to generate type II APAP samples, intrinsic dissolution with a compressed 
disk of known area was employed to eliminate surface area and surface electrical charges 
as dissolution variables. The dissolution rate so determined can be correlated with the 
physical properties of the sample [76].  
(a)                                                                  (b) 
Figure 3.11 Dissolution profiles for acetaminophen samples based on (a) Conventional 
dissolution rate, and (b) Intrinsic dissolution rate (IDR). 
 
Figure 3.11 (b) shows the linear IDR profile of a compressed disk under sink 
conditions. Both modified type II APAP (MAPAP II and SiO2 APAP II) show increase in 
dissolution profile compared to results from conventional dissolution. Improved IDR for 
MAPAP II indicates that micronization not only promotes sample stabilization but also 
modifies the surface area resulting in the highest dissolution rate. From the dissolution 
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profile of the stable type I APAP phase, it can be concluded that it dissolves the slowest, 
whereas the corresponding metastable type II APAP has improved release profiles. Dry 
coated type II APAP also showed improvement in mass release, but the improvement 
relative to type I APAP is small.   
 
3.7 Conclusions 
New interfaces in type I APAP were created by micronization or by dry-coating with 
nanosized silica. Raman spectroscopy was utilized, among other analytical (XRPD and 
SEM) and dissolution techniques to, respectively, monitor the stability and determine the 
dissolution profile of the newly developed type II APAP phase. Raman studies conducted 
on the stabilized metastable type II phase as a function of time showed stability for over 
18 months; however, a diffuse scattering background superimposed on the Raman 
spectra, observed previously in griseofulvin, developed with time and was attributed to 
the growth of nanosized nuclei of the stable type I polymorph in the type II phase matrix 
of the particles. No molecular changes at the new interfaces were, however, detected 
based on the Raman spectra taken as a function of time. In addition, improved dissolution 
profiles for the stabilized type II APAP relative to the type I phase were observed. The 
results obtained therefore indicate the potential of the stabilized type II APAP phase for 
use in pharmaceutical applications.  
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CHAPTER 4 
IN-LINE AND OFF-LINE RAMAN SENSING OF PHARMACEUTICAL 
DOSAGE FORMS 
 
1.4 Raman Spectroscopy as a Sensing Tool 
Raman spectroscopy is a significant analytical tool for process understanding in the 
pharmaceutical industry. Process and bench top applications exist for Raman 
spectroscopy and can be applied for qualitative and quantitative process evaluation.  
Successful pharmaceutical applications include blend uniformity, reaction monitoring, 
solid quantification, coating monitoring and probably most significantly, crystallization 
monitoring and polymorph detection and analysis [3]. Significant technological 
development in the area of instrumentation has allowed the implementation of fiber 
optics, immersion and big spot size probes, and dispersive components into Raman 
systems, making them highly robust and versatile tools for on-line, in-line, and off-line 
characterization in the pharmaceutical industry [4].  
Spectral imaging using Raman spectroscopy is a common tool for chemical 
characterization of various pharmaceutical dosage forms [8, 24, 77] including the newly 
developed thin polymeric films in Test Bed 2 of the NSF-Engineering Research Center 
[24]. Since the film’s design employs small API particles, for example that of 
griseofulvin uniformly dispersed in a film composition, it is an excellent micro- and 
nano-particle based system for alternative delivery. Performance and drug behavior is 
based on the film’s advanced functionality and ability of the active media to maintain
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small particles ranging between 10 µm to 300 nm in a non-agglomerated form. This 
makes it possible to precisely control the release of the drug.  
Low dissolution rates of poorly soluble drugs [27, 78, 79] and content uniformity 
of drugs administered in low doses [80-82] are the most common issues encountered by 
the pharmaceutical industry. In films, the small particle size in a uniformly dispersed 
configuration can significantly affect some of the commonly encountered problems by 
potentially enhancing the dissolution rate of poorly soluble drugs, in particular 
griseofulvin, and the content uniformity of drugs administered in low doses.  
Since the crystalline state of any API affects its use in pharmaceutical applications 
as a drug processed into pills or capsules for pharmaceutical applications, it is necessary 
to develop effective, fast, and non-destructive methods that would allow elimination of 
crystalline defects and potential polymorph formation [6-8]. Implementing Raman and 
NIR spectroscopic techniques as on-line and in-line sensing tools, provides molecular 
level understanding and monitoring of solid-state behavior, uniformity, and particle size 
distribution in a dosage form.  
In this Chapter, Raman imaging provides the spatial distribution of micro- and 
nano-sized griseofulvin in the polymeric films and explores the possibility for developing 
innovative dissolution methods based on drug allocation on the film’s surface [24]. 
Various film compositions were prepared and analyzed by Raman imaging [39]. In 
addition, complementary Raman and NIR imaging (by Jarez, Zarow et al [24]) was 
performed on a set of four films and will be discussed below.   
Raman spectroscopy is also used to demonstrate the feasibility of in-line Raman 
spectroscopy to dynamically monitor the crystallinity and particle size of griseofulvin in 
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stable nanosuspensions that are being developed (Bhakay, to be published). The behavior 
of griseofulvin nanosuspensions will be presented and discussed in sections below.   
     
    4.2 Chemical Mapping and Imaging 
Applications of vibrational spectroscopy, Raman and NIR in particular, have gained 
significant recognition in the pharmaceutical community as techniques for analyzing 
solid dosage formulations [72, 83-86].  The concept of chemical imaging is relatively 
new as it was developed and applied to pharmaceutical samples in the mid-1990s [87]. It 
was quickly realized that this techniques can offer much needed understanding and detail 
information to solve problems related to product development.  Both Raman and NIR 
chemical imaging (CI) provide chemical and physical information at different scales of 
scrutiny [24]. The presence of specific spectral bands can be used to identify components 
of the formulation, their spatial distribution, particle sizes, and most importantly their 
crystallinity and polymorphic states. The main advantage of using vibrational techniques 
is characterization of dosage forms on an as-received basis with no sample preparation. 
NIR and Raman spectroscopy, given their complementary origins, result in characteristic 
vibrational spectral features. NIR spectra show broad second-order bands due to 
combinations and overtones of fundamental vibrations which sometimes are difficult to 
assign to the individual functional groups [88]. On the contrary, Raman-active vibrations 
above 200 cm-1 are associated with narrower first-order spectral lines resulting from 
interatomic bond vibrations [6]. In the solid-state, the line-shapes and line-widths, and 
splittings of these narrow bands can also provide important information on the 
crystallinity of the investigated material [23].  
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Among the advantages of using Raman CI for characterization of formulations 
during pharmaceutical development and manufacturing processes are: chemical 
visualization of spatially resolved components of a sample mixture at a microscopic 
scale, visualization of impurities and degradants generated during processing, 
determination and quantification of different physical forms, and low limits of detection 
per mapped area (better than 0.025 %) [8, 89, 90]. The main disadvantage of Raman CI is 
the long acquisition time necessary compared to NIR-CI, and if the mapped area is 
relatively small, a large number of maps are required to be representative of the bulk 
sample.    
Principle of Raman Imaging: Raman CI can be acquired using point and line mapping, 
or global illumination. Independent of the mapping technique used, the collected data 
result in generation of the same chemical image, also called hyperspectral data cube [91] 
presented in Figure 4.1 (a). This 3D block contains two types of data:  spatial, composed 
of x and y coordinates and spectral, composed of wavelength and intensity. Due to the 
detector design, the 3D cube results, however, in a 2D representation.  
During point mapping, the sample area is selected first using the microscope to 
focus on the specific detail or location on the surface.  The area is then divided into 
mapping points and the hyperspectral data cube is generated by acquiring the entire 
Raman spectrum (or specific range) at each point for all points as shown in Figure 4.1 
(b). The line mapping is obtained in similar fashion, except the laser source is stretched 
into a line and results in timely completion of the map [92] comparing to point mapping 
[Figure 4.1 (c)]. When a global illumination technique is used, the selected sample area is 
exposed to defocused laser radiation allowing coverage of a much larger area as shown in 
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Figure 4.1 (d). The sample response is obtained at a specific wavelength simultaneously 
for the entire illuminated area. Since point and line techniques collect high quality Raman 
spectra, and are not wavelength specific, they generate a wealth of chemical information 
from the mapped sample area.  Global illumination, on the other hand, is a much faster 
technique but may result in poor chemical information since the emphasis is on the 
spatial information.  
(a) 
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            (b)                                      (c)                                     (d) 
 
 
 
 
 
 
 
Figure 4.1 Schematic representations of hyperspectral cube and approaches to chemical 
imaging: (a) Methods of acquiring the hyperspectral cube; (b) Point mapping; (c) Line 
mapping; and (d) Illumination. 
 
To visually represent a hyperspectral data cube as a chemical image, various 
statistical tools need to be implemented. It should be remembered that a hyperspectral 
data cube represents a set of raw data and can become a chemical image that shows 
intensity variation of these raw data only upon statistical processing. The data processing 
tools used in this study are described in section 4.3.  
 
4.3 Analysis of the Hyperspectral Data Cube  
During acquisition of a spectral image, a very large amount of data is collected. For 
example, a Raman hyperspectral data cube with spatial dimensions of 20 µm x 20 µm and 
120 x 120 pixels can result in 14400 spectra, each with approximately 3000 data points. 
To extract the relevant chemical, physical and spatial information from such a dense 
dataset, various statistical algorithms need to be employed. This practice has led to the 
development of a new chemical field that is also known as chemometrics [6]. The 
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majority of commonly used chemometrics techniques rely on univariate and multivariate 
classification of the data. For a univariate approach, only a specific wavenumber of each 
component is selected to create a chemical image, whereas multivariate analyses take into 
account all spectral information contained in the data cube and employ techniques like 
Principal Component Analysis (PCA) [93], Partial Least Squares (PLS) [94], or Direct 
Classical Least Square (DCLS) to produce a chemical image.  
Typical steps in a data analysis procedure consist of unfolding a three-
dimensional data cube into a two-dimensional representation, preprocessing, 
classification of data, and image processing [77]. Data preprocessing is usually 
performed to remove the non-chemical biases that arise form scattering effects due to 
surface roughness, particle size, random noise, or optical effects. These techniques 
include mathematical methods such as:  
 Standard Normal Variate (SNV) – identical to auto-scaling, reduces slope 
variation from spectrum to spectrum.  It results in a similar background in all 
spectra and therefore enhances the differences due to band intensities    
 Smoothing – improved S/N ratio by averaging signal over many spectra using 
Fast Fourier transform (FFT) or Savitsky-Golay methods 
 Mean-centering – subtracting the mean from all spectral data resulting in the 
shift of the data towards the mean 
 Normalization – results in similar scale of the intensity range for all spectra. 
 Baseline Flattening – polynomial functions are used to fit a baseline followed 
by its subtraction from the spectral baseline  
 Derivatives – 1st and 2nd are most commonly used. They eliminate slopes or 
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curved background in spectra due to fluorescence, structural defects, or 
Rayleigh wings and resolve peak overlaps [6].  
After data preprocessing, qualitative and/or quantitative analysis is performed. 
Among the most recognized processing methods are PCA, PLS, and DCLS, which are 
explained briefly below.    
In case of PCA, a set of orthogonal representations is found for the analyzed data 
cube by expressing the data matrix (M) as the product of two other matrices – the scores 
matrix T and the transpose of the loadings matrix L as in the following equation 4.1: 
 
                                                                X = TLT                                                          (4.1) 
 
PCA gives information on the most variance in the observed variables and is used as a 
prediction or criterion of a variable in subsequent analyses [91]. While PCA calculates 
loadings independently of the concentrations of the components, in PLS spectra are 
highly correlated to the concentrations resulting in loadings that account for the 
maximum variance in both the spectra and the concentrations [6]. PLS classification can 
be also calculated using pure reference spectra to extract the distribution map. This 
technique is called PLS discriminant analysis (PLS-DA). Another chemometrics 
technique is DLCS, also known as Ordinary Least-Square algorithm (OLS). DLCS finds 
linear combination of data from pure components and creates a combination that most 
closely matches the original data providing quantitative estimates of the concentrations 
[95].  
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 In the research presented, polymeric films 1-3 and 5 were analyzed by PLS-DA 
and the results are explained in the following section. All of the remaining films were 
analyzed using a DCLS algorithm.  Particle size calibration was performed using the 
univariate method. 
 
4.4 Experimental Details 
Griseofulvin, a poorly soluble drug, was used as a model active pharmaceutical 
ingredient (API) in micronized and nanosized forms. The total of nine films was 
investigated in this study to determine the distribution of the embedded griseofulvin in 
the polymeric matrix. Hydroxypropyl methylcellulose (HPMC) was selected as the film-
forming excipient for all films. In some cases, sodium dodecyl sulfate (SDS) and glycerol 
(GLY) were added as surfactant to the HPMC matrix, as indicated in Table 4.1. 
Micronized griseofulvin and HPMC were purchased form Sigma-Aldrich Corporation 
(Milwaukee, WI), SDS was purchased from Fisher Scientific (Fair Lawn, NJ), and GLY 
was supplied by J. T. Baker Inc (Phillipsburg, NJ). Films labelled as 6, 7, 8 and 9 were 
prepared from griseofulvin nano-suspensions with particle size of approximately 260 nm. 
Films labelled as 12C, 1, 2, 3, and 5 were prepared form micronized griseofulvin with a 
particle size of 10 µm.   
4.4.1 Preparation of Griseofulvin Films and Nanosupensions 
Films 1, 2, 3, and 5: Blends of micronized API and HPMC were prepared by first 
dispersing the two components together in hot water (80oC), followed by stirring for 12 
hours and drying at room temperature. The films produced have a thickness on the order 
of 100 µm.  A total of five film batches were prepared but only four films were selected 
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for this study as indicated in Table 4.1 and analyzed by Raman mapping and NIR-CI. 
Since only films with different drug concentrations were considered, film 4 was not 
studied because it had the same concentration as film 2.  Every sample was analyzed by 
the two imaging methods, Raman and NIR spectroscopy. However, the instrumental 
setup precludes the possibility of analyzing the exact same region of the film by the two 
methods.  
Films 12C: Prepared as films 1, 2, 3, and 5 above with addition of different SDS and 
GLY amounts during the dispersion of the blends as indicated in Table 4.1.   
Films 6, 7, 8, and 9: Blends were prepared in the same fashion as for film 12C and 
milled using a MicroCer media mill from Netzsch Fine Particle Technology (Exton, PA) 
with 400 µm zirconia beads and milling speed of 3200 rpm to generate sub-micron 
particles. Upon media milling completion, t = 64 minutes, stable griseofulvin 
nanosuspensions were obtained and used to cast films dried at various temperature 
conditions as indicated in Table 4.1. Particle size analysis at t = 64 minutes was 
performed with Beckman Coulter LS13320 laser diffraction particle size analyzer from 
Beckman Coulter (Brea, CA) , and determined to be in a range of 240 nm (D90).  
Griseofulvin Nanosuspension:  For in-line particle size characterization and crystallinity 
study of griseofulvin nanosuspension, new blends were produced with the following 
concentration: 8.84% (w/w) griseofulvin, 2.21% (w/w) HPMC, and 0.44% (w/w) SDS; 
and media milled using same technique as in case of films 6 through 9.  During media 
milling, periodical sampling of the suspension was performed at t = 1, 2, 4, ….64 
minutes. Laser diffraction spectrometry was used to analyze the particle size of the 
collected samples.  Results of particle size analyses are presented in Table 4.2. Solid-state 
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analysis of griseofulvin nanosuspensions was performed by collection of static and 
dynamic (suspension was magnetically stirred) Raman spectra recorded with a fiber optic 
Raman spectrometer.   
 
Table 4.1 Prepared Compositions of Griseofulvin Films 
 
Film Name 
 
Griseofulvin 
(%) 
 
HPMC 
(%) 
 
SDS 
(%) 
 
GLY 
(%) 
Drying 
Temperature (°C) 
1 57.00 43.00 - - 25.00 
2 50.00 50.00 - - 25.00 
3 44.00 56.00 - - 25.00 
5 36.40 63.60 - - 25.00 
12C 9.30 69.70 0.02 20.90 25.00 
6 49.14 29.66 2.00 18.76 25.00 
7 37.63 51.97 1.87 8.51 25.00 
8 37.63 51.97 1.87 8.51 50.00 
9 37.63 51.97 1.87 8.51 42.00 
 
 
 
 
 
 
77 
 
 
Table 4.2 Particle Sizes of Sampled Griesofulvin Nanosuspensions 
 
Milling Time (min) 
 
Particle Size [D90 (µm)] 
 
Particle Size [Mean (µm)] 
0.00 
1.00 
2.00 
4.00 
8.00 
16.00 
32.00 
48.00 
64.00 
7.29 
6.16 
5.71 
4.71 
1.63 
0.73 
0.48 
0.31 
0.24 
3.96 
3.18 
2.86 
2.07 
0.92 
0.48 
0.26 
0.19 
0.16 
 
4.4.2 NIR Chemical Imaging 
The near infrared hyperspectral images were obtained by Jerez at the University of Puerto 
Rico, Mayaguez and acquired using a SyNIRgi (Spectral Dimensions Inc., Olney, MD) 
instrument. The images were obtained in the diffuse reflectance mode with a spatial 
resolution of 320 X 256 pixels. A 10 μm per pixel objective was used to analyze a film 
area of approximately 3.2 x 2.6 mm. The spectra were obtained with 5 scans in a spectral 
range of 1200-2400 nm. Two different areas within the same gel strip film were analyzed.  
4.4.3 Raman Chemical Imaging   
Films 1 - 3, 5 and 6 - 9: Raman mapping spectra were collected using a Jobin 
Yvon/Horiba LabRAM micro-Raman spectrometer, with 632.81 nm He/Ne laser 
excitation and a 10x objective. For higher magnification objectives, such as 50x and 
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100x, significant de-focusing was observed on the sample surface due to heating, which 
precluded mapping experiments. The Raman spectra were recorded in the 800-1650 cm-1 
range. The films were analyzed “as is,” without sample preparation or modification, and 
no sample damage was observed during the experiment.  The data collected were 
analyzed using the Malvern NIR Instrument’s Isys software to generate chemical images.  
For films 1 - 3 and 5 a typical chemical map consisted of 30 x 30 pixels, with a 
step size of 0.3 μm.  The mapping was performed by acquiring Raman spectra from thirty 
points in the x direction and 10 µm distance and repeating the same for 10 µm in the y 
direction. Since the laser was moved by 0.3 µm each time, a new Raman spectrum was 
acquired, which resulted in high sampling frequency along both directions giving higher 
spectral content and therefore more accurate information on chemical behavior and 
borders of particle domains. This relatively high sampling frequency at the laser spot size 
results in sampling of 10% of new area at each step size, giving more thorough chemical 
evaluation of the film components. Each spectrum was acquired for 3 seconds at each 
pixel or stage position resulting in a total acquisition time of 1 hour and map size of 
approximately 10 μm x 10 μm. Achievable laser spot size and spatial resolution of the 
micro-Raman spectrometer were calculated to be 3 µm and 1.5 µm respectively and were 
calculated based on lateral spot size (1.22λ/numerical aperture), and spatial resolution = 
0.61λ/numerical aperture) [96]. Four maps were recorded for films 1-3 and 5. Films 3 and 
5 were subsequently re-analyzed resulting in an additional five maps for films 3 and 5.   
Chemical maps for films 6 - 9 consisted of 30 x 30 pixels with step size of 1 µm. 
Raman spectra were acquired from thirty points in the x direction and 30 µm distance and 
repeating the same for 30 µm in the y direction resulting in the 30 µm x 30 µm mapped 
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area. Single Raman spectrum acquisition time and total mapping acquisition time were as 
above.   
For film 12C, chemical maps were performed with a Jobin Yvon/Horiba 
LabRAM Aramis confocal Raman microscope using 632.8  nm He/Ne laser excitation 
and a 100x objective with a spatial resolution of 1 µm. Two maps form independent 
locations on the film were recorded. Location 1 map comprised of 60 x 60 pixels with 0.5 
µm step size resulting in the approximately 30 µm x 30 µm mapped area. Location 2 map 
consisted of 90 x 60 pixels with 0.5 µm step size resulting in the approximately 30 µm x 
45 µm mapped area.  
 
4.4.4 Raman Instrumentation for Solid-State and Particle Sizes Sensing 
Solid-State Raman Spectra of Griseofulvin Nanosuspensions: An EZRaman LE 
Raman Analyzer System from Enwave Optronics with a HRP 8 high throughput fiber 
probe and a 250 mW 785 nm laser focused at a working distance of 6 mm was used for 
simulated in-line measurements of crystallinity of griseofulvin nanosuspensions. Raman 
spectra were collected with 10 seconds acquisition time each.  
Griseofulvin Particles Sizes in Nanosuspensions: EZRaman LE Raman Analyzer 
System coupled to MicroVievew adapter with a 4x objectives and 15 µm spot size; and 
Mesophotonics SE1000 Raman spectrometer with a 300 mW power 785 nm excitation 
laser and 130 µm diameter spot size were used to measure the particle sizes of 
griseofulvin in nanosuspensions. Each sample measurement corresponded to an average 
of 5 scans, each 10 seconds long, totaling 50 seconds in scanning time.  
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4.4.5 Data Treatment 
Data Treatment for NIR Spectra (Films 1-3 and 5): The data were analyzed using the 
Malvern NIR Instrument’s Isys vresion 5.0.0.14 software. The logarithm, log10(1/R), was 
first applied to the data cube to convert the spectra to absorbance units. Bad pixels were 
replaced by the average response of the neighboring pixels. A low-pass Fourier filter was 
applied to reduce spectral noise caused by the use of transflectance for a semi-transparent 
matrix. The spectra were normalized using the Standard Normal Variate and Savitzky-
Golay second derivative (filter order 3, filter width 9) [24].   
Data Treatment for Raman Maps: The data were analyzed using the Malvern NIR 
Instrument’s Isys version 5.0.0.14 software.  Raman spectra were collected in the 850  to 
1650 cm-1 frequency range. A spatial mask was initially applied in order to eliminate 
background pixels, followed by a low pass filter, baseline correction, normal standard 
variate (SNV) transformation and Savitzky-Golay second derivative (filter order 3, filter 
width 13). The resulting spectra were obtained from 850 to 1650 cm-1 frequency range. 
Partial least squares discriminant analysis (PLS-DA) was performed to provide a 
chemical image based on the distribution of the drug throughout the film. For films 6 - 9, 
same data pretreatment was applied as above followed by univariate analysis of the 820 
cm-1Raman line intensity for the solid-state characterization of the films produced from 
griseofulvin nanosuspensions. For film 12C, data processing was performed by using 
Jobin Yvon/Horiba LabSPEC 5 version 5.42.18 software. The collected map was 
normalized and analyzed using the Direct Classical Least Square (DCLS) technique.   
Data Treatment for In-Line Particle Size Raman Spectra: Data collected were 
analyzed using Mesophotonics SE1000 Raman instrument’s ACD/Labs SpecManager 
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version 12.01 software. All Raman spectra were normalized and smoothed by a Savitzky-
Golay filter (order 5, width 11) and analyzed using the univariate method by monitoring 
822 cm-1 and 1706 cm-1 Raman lines intensities at each sampling interval. The Raman 
line at 822 cm-1 is known to be attributed to cyclohexanone ring stretching vibrations and 
disappears with decrease in crystallinity of the sample as reported by Zarow et al [23]. 
 
4.5 Sensing of Films and Nanosuspensions 
4.5.1 Films 
The overall objective of this chapter is to use results of off-line Raman spectroscopic 
characterization, such as those described in Chapters 2 and 3, to help interpret on-line 
Raman monitoring performed in the test-beds of the ERC. Off-line Raman mapping was 
performed for griseofulvin films of various concentrations and analyzed for particle 
distribution, quantification and defect formation. In addition, complementary NIR and 
Raman chemical analyses were performed for some of the films [24]  to investigate the 
presence of agglomerates and the solid-state morphology of embedded particles.  The 
goal of off-line imaging is to provide input to in-line Raman data interpretation 
particularly regarding the homogeneity of dosage forms in pharmaceutical films and 
tablets. Previous studies have used NIR-CI for polymeric films containing dissolved API 
[97] whereas in this study the drug particles are suspended in the matrix. Partial Least 
Squares Discriminant Analysis (PLS-DA) and Direct Classical Least Square (DCLS) are 
performed to develop a chemical image based on the spatial distribution of the drug 
throughout the film for various films [24]. 
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a) Film 12C  
Distribution of griseofulvin particles embedded in a pharmaceutical film is crucial to 
determining the optimal preparation conditions and monitoring any morphological 
changes during film fabrication. Figures 4.2 (a) and (b) represent Raman chemical maps 
and Raman chemical images resulting from data processing of two independently 
mapped locations on film 12C with 9.30 wt% API, 69.7 wt% HPMC, 20.9 wt% GLY and 
0.02 wt% SDS respectively. Chemical images correspond mostly to the API particles, 
shown in light blue or green, and HPMC shown in red. The shades of blue/green indicate 
API scattering intensity which changes due to the topology of the film and uneven HPMC 
coverage. The mapping data indicate no chemical or structural changes of the API and 
shows drug agglomerations into larger particle regions from 5 to 10 µm. There are also 
smaller particles of size less than 5 µm.  
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(a)                                                       (b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Raman chemical analysis of film 12C: (a) Raman chemical maps of 
griseofulvin distribution for location 1 (top) and 2 (bottom) on the film, and (b) Raman 
chemical images developed for location 1 and 2 using DCLS analysis.  
 
b) Films 1, 2, 3, and 5  
 
NIR Mapping – Due to the large overlap between NIR bands for griseofulvin and 
HPMC, second derivative spectra were obtained and the absorption band at 2080 nm was 
used since it represents an important change of slope in the spectrum of griseofulvin [24]. 
Figure 4.3 shows resulting NIR chemical images and histograms of griseofulvin films. 
Films 1, 3 and 5 show differences in the variation of the distribution in each histogram, 
associated with differences in the distribution of HPMC and griseofulvin in the film. The 
binary image analysis, not shown here, confirmed the absence of large clusters in the 
film. However, in films 1 and 4 the particles are not as widely dispersed as in the other 
films. The particles are widely dispersed when the area covered is higher, and more 
aggregated when the area covered is reduced [24].  
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Figure 4.3 Near IR chemical images and histograms for the different components within 
the films 1, 2, 3, and 5 at 2080 nm [24].  
 
 
Raman Mapping - Figure 4.4 shows Raman spectra of individual film components, 
HPMC, griseofulvin, and composite HPMC-griseofulvin film.  The boxed region 
indicates the spectral region with the strong 1620 cm-1 griseofulvin band [23]. The 
HPMC-griseofulvin film spectra were obtained in spectral regions, as in film 3, where the 
1620 cm-1 band intensity is high and HPMC lines are not interfering. Pure HPMC and 
griseofulvin spectra from film 3 were used to create a reference library based on partial 
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least squares discriminant analysis PLS-DA. The image scores are based on the degree of 
association of each pixel with the reference library; higher scores indicate a spectrum 
more similar to the loading.  A red-green (RG) color-coded composite image was 
developed to show the localization of two components simultaneously.  Figure 4.5 (a) 
shows the false color spatial mapping for the predicted distribution of API (red) and 
HPMC (green) in the four films. The corresponding image represents a sample area of 
about 100 µm2 hence providing a high resolution view of the distribution of the API 
particles in a smaller area. Higher spatial resolution is therefore obtained by micro-
Raman mapping, and this method could also eventually detect the presence of 
inhomogeneity, impurities and/or API polymorphs in the films [98]. The spectra obtained 
were compared to those from a prior study where the structural disorder induced by 
cryogenic milling and by heating to the amorphous phase in the active pharmaceutical 
ingredient were studied using Raman spectroscopy, X-ray powder diffraction (XRPD), 
and fluorescence spectroscopy [23]. For griseofulvin films, Raman mapping analysis did 
not show any solid-state transition, such as amorphization upon film formation, as 
determined by the enhanced intensity of a characteristic Raman line for crystalline 
griseofulvin at 820 cm-1 reported by Zarow et al [23]. 
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Figure 4.4 Raman spectra of griseofulvin, HPMC, and HPMC-griseofulvin. The boxed 
region shows lines associated only with griseofulvin.   
 
PLS-DA provided an assessment of drug distribution throughout the films. Table 
4.3 summarizes the results showing that the predicted values agree closely with the 
nominal concentration values, except for film 2. However, the small area analyzed (≈ 100 
µm2) might not be representative of the concentration in the film. Therefore, five 
different areas of films 1 and 5 were further analyzed. Table 4.4 shows that the average 
value of five measurements is close to the nominal value of the film, however, area 4 in 
film 1 and area 2 in film 5 show significant differences between predicted and nominal 
concentrations. The results obtained indicate that the sampling error resulting from the 
small area analyzed is likely the main reason for the difference in the prediction.  
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Table 4.3 PLS-DA Concentration Prediction of Griseofulvin and HPMC in Films 1, 2, 3, 
and 5  
 
 Film 1 Film 2 Film 3 Film 5 
API  
Nominal 57.0% 50.0% 44.4% 36.4% 
API 
Predicted 50.0% 62.0% 44.0% 34.0% 
 
Table 4.4 PLS-DA Concentration Prediction of Griseofulvin in Analyzed Areas of Films 
1 and 5 
 
 Predicted Value of Griseofulvin 
Average 
Area 1 Area 2 Area 3 Area 4 Area 5 
Film 1 59.0% 55.0% 59.0% 48.0% 54.0% 55.0% 
Film 2 33.0% 56.0% 36.0% 36.0% 31.0% 38.0% 
 
 
Figure 4.5 (b) shows the histograms based on PLS-DA scores for the different films. The 
histograms show a very low number of areas with high scores. The high scores are 
indicative of high concentrations of HPMC or griseofulvin.  However, a large number of 
areas are observed where the scores range from 0.4 – 0.6 indicating a lower concentration 
of the griseofulvin or polymer. These intermediate concentration values indicate that the 
Raman method is detecting both griseofulvin and polymer, and that these are mixed 
throughout the film at a fine scale. Raman spectra acquired through high frequency 
sampling of the 10 x 10 µm mapping area provided a thorough chemical evaluation.  This 
type of information is unique to hyperspectral images and is not available from spectra 
recorded from sample averaging or integrating spectrometers. 
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c) Films 6, 7, 8, and 9 
 This set of films consisted of films manufactured using various concentrations of 
griseofulvin nanosuspensions and dried at different temperatures. It was of great 
importance to study the effect of film formation on nanosized drug in suspensions and to 
monitor crystallinity and particle size distribution in resulting thin films. Figure 4.6 
shows black-white (BW) color-coded composite images developed by monitoring the 822 
cm-1 griseofulvin Raman line using univariate analysis where black-white colors 
correspond to low and high intensity of the line, respectively. For griseofulvin films 
manufactured from nanosuspensions, Raman mapping analysis, at a given resolution, did 
not show any solid-state transition, as determined by the presence of the characteristic 
Raman line at 820 cm-1 [23]. At this early stage of analysis, it was concluded that the 
chemical composition of the drug embedded in the films was not affected by the 
manufacturing conditions. Distribution and size of griseofulvin particles could not be 
determined at this time since the Raman chemical images showed no individual particles 
or agglomerations throughout the mapped areas shown in Figure 4.6.  
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(a)                                                            (b) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 (a) Red-Green (RG) color-coded Raman images where red represents the 
distribution of the API, griseofulvin and green that of the excipient, HPMC; and (b) 
Histograms providing quantitative descriptions of griseofulvin and HPMC contents for 
films 1, 2, 3, and 5. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6 Black (low intensity of the 820 cm-1 Raman line) - White (high intensity of 
820 cm-1 Raman line) color-coded Raman images of griseofulvin nanosuspension films 6 
through 9 processed with the univariate method.  
 
Film 6 Film 7 
Film 8 Film 9 
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4.5.2 Nanosuspensions 
The effect of media milling on newly developed stable suspension of griseofulvin of 8.8 
wt% nano-sized griseofulvin and HPC-GLY-SDS composites was studied. The stable 
suspension at various griseofulvin concentrations was later used to manufacture thin 
films by casting.  The structural and chemical stability of nanosized drug particles in 
formulated suspensions were studied. Media milling was used to increase the 
bioavailability of this poorly soluble drug by decreasing its particle size. The previous 
study of cryomilled griseofulvin with particle size of the order of 300 nm, resulted in 
formation of structural disorder and loss of crystallinity on processing [23]. Since media 
milling generated nanosized griseofulvin in a similar size range of approximately 240 
nm, it was critical to study the effect of media milling on the solid state properties of 
griseofulvin. The structure of the nanosized particles were determined based on the 
characteristic Raman lines for crystalline griseofulvin in the 500 to 850 cm-1 spectral 
range [23]. An initial study of dynamic and static Raman spectra, collected by a fiber 
optic Raman spectrometer to simulate in-line monitoring of the solid-state of the drug in 
suspension, showed no indication of an amorphous component in nanosized griseofulvin 
in the stable suspension (Figure 4.7).  
 
  
 
 
 
 
91 
 
 
Dynamic Mode 
Static Mode 
 822 cm
-1
 
Crystalline 
Amorphous 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7 Simulation of on-line crystallinity monitoring of griseofulvin nanosuspension: 
(a) Photograph showing set up for the acquisition of dynamic and static Raman spectra 
with a fiber optic Raman spectrometer, and (b) Recorded Raman spectra in dynamic (top) 
and static (bottom) modes. Boxed region shows vibrational spectral differences between 
amorphous and crystalline griseofulvin.  
(a) 
(b) 
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The dependence of Raman scattering on particle size has been widely investigated 
mostly for inorganic materials. Wang et al [13] studied the intensity of the Raman signal 
in pressed powders  using a fiber optic spectrometer similar to that employed in this 
work, in relation to the particle size for a range of inorganic compounds. They found a 
decrease of Raman intensity with increasing particle size which was attributed to 
increased diffuse reflectance for larger particles. Iqbal et al found an increase in Raman 
linewidths and decrease in peak frequencies in nanoscale silicon below crystallite sizes of 
10 nm [99, 100] which is widely recognized today as associated with quantum 
localization in nanocrystals and quantum dots. In the present study, the objective was to 
investigate the average particle size of griseofulvin in nanosuspensions (with particle 
sizes well above the quantum limit but below the size range investigated as referenced) as 
a function of milling time by a combination of laser diffraction and Raman spectroscopy. 
The intensity of the 1706 cm-1 Raman line increases with decreasing particle size in 
agreement with Wang et al due to increased laser light throughput or decreased diffuse 
reflectance in suspensions with smaller particles.  
Calibration models for particle size prediction of nanosized drug suspensions 
were created for multiple sets of data collected with two Raman instruments operating in 
the micro and fiber optic modes with different laser spot sizes of 15 µm and 100 µm, 
respectively. Different Raman instruments were employed to minimize the influence of 
particle size on calibration models. In all data sets, the Raman signal intensity used for 
calibration was taken as the difference between the maximum of the 1706 cm-1 Raman 
line and a baseline constructed from the minima immediately adjacent to the peak.  First 
the calibration model was built to determine sensitivity of the instruments by monitoring 
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normalized peak intensity as a function of recorded spectrum at each particle size. Mean 
values for normalized intensity at each particle size was also calculated. Figure 4.8 shows 
a calibration model built for data collected with a laser spot size of 130 µm which 
resulted in much better correlation of the signal intensity to the spectrum number, R2 = 
0.95 (Mean R2 = 0.97), comparing to data collected with the much smaller laser probe of 
a micro-Raman instrument, R2 = 0.67. The variation in the R2 values is mostly related to 
the sensitivity of Raman instruments and laser probe spot size. Higher peak noise and 
therefore lower R2 (R2 =0.67) value is reported for the instrument with smaller probing 
size. Based on the following determination, the remaining collection of Raman data was 
performed using the instrument with larger laser spot size. Variation of the peak intensity 
was next correlated with particle size values from laser diffraction analysis. Table 4.2 
shows D90 and mean values of particle size measurements for griseofulvin 
nanosuspension as a function of milling time. For calibration purposes, the D90 value 
was used as it represented the particle size for the 90% of the sample. D90 along with 
larger laser spot size resulted in a better correlation value when compared to the mean 
value and larger laser spot size, R2D90 = 0.94 vs R2MEAN = 0.87 respectively. Figure 4.9 
shows the results of the particle size calibration based on intensity of the 1706 cm-1 
Raman line for the data set collected with larger, 130 µm laser probe size for D90 and 
mean size of griseofulvin particles.  
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Figure 4.8 Calibration model representing normalized Raman spectra as a function of 
various particle sizes of sampled griseofulvin nanosuspensions: (a) Using all values of 
normalized intensity, (b) Using mean values of normalized intensity. Calibration 
performed by monitoring 1706 cm-1 Raman line in set of data collected with 130 µm laser 
spot size.  
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Figure 4.9 Correlation of D90 (top) and mean (bottom) particle sizes with normalized 
intensity of the 1706 cm-1 Raman line for griseofulvin nanosuspensions.  
 
 
4.6 Conclusions 
Polymer films loaded with small (low micron or submicron sizes) API particles represent 
API composite materials with many possibilities for functionalization and use as drug 
delivery matrices in different types of dosage forms. Trapping fine API particles in a 
polymeric matrix offers an advantageous way of harvesting engineered particles. The 
NIR-CI method provides an image of the spatial distribution of the trapped particles in 
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just a few minutes, and is currently being used to optimize the pharmaceutical 
formulation and its manufacturing process. Raman mapping on the other hand is being 
used to complement NIR-CI as discussed here (currently in a less frequent basis), and its 
primary role is to monitor the crystal form of the API, presence of defects and particle 
size distributions at the sub-micron level. Raman mapping and NIR-CI are two 
complementary spectroscopic techniques, which combined, provide detailed information 
about the distribution of API particles as well as chemical detail regarding the interaction 
between the drug and the polymer. Raman chemical imaging of thin films fabricated in 
an ERC Test Bed for film manufacture from micronized and nanosized griseofulvin 
suspensions confirmed the crystallinty of the embedded drug. This can result in even 
more innovative film design for poorly soluble drugs like griseofulvin, and can 
consequently enhance the dissolution profile and content uniformity of the formulation. 
In addition, applications of Raman spectroscopy for particle size and solid-state 
monitoring of griseofulvin suspensions during media milling showed that this technique 
is capable of on-line quality control during pharmaceutical manufacturing processes.  
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CHAPTER 5 
SURFACE ENHANCED RAMAN SPECTROSCOPY (SERS) OF 
PHARMACEUTICAL AND STRUCTURALLY RELATED ENERGETIC 
MOLECULES 
 
5.1 Overview 
Trace level identification of chemical entities plays an important role in pharmaceutical, 
biological and environmental sciences, and in security applications [85, 101, 102]. 
Typical analytical techniques rely on the use of chromatographic methods (HPLC, GC) to 
separate and identify individual components. However, the chemical information 
obtained by this identification, is based mostly on UV-visible or fluorescence 
spectroscopic data which lack direct structural and molecular information of individual 
components of a complex system [103, 104]. Surface enhanced Raman spectroscopy 
(SERS) has been shown to be sufficiently sensitive for analytical applications in the 
pharmaceutical industry with the capability ultimately of single molecule detection [105, 
106].  
Discovery of SERS phenomenon was first observed in 1973 by Fleischman et at 
[107] who observed strong enhancement of the Raman signal from pyridine molecules 
adsorbed on a silver electrode. Few years later, in 1977, the phenomenon was also 
independently reported by Jeanmarie and Van Duyne [108] and Albrecht and Creighton 
[109]. SERS involves enhancement of the Raman signal via surface plasmons on, for 
example, nanostructured gold or silver nanowire substrates.  Since the discovery, SERS 
has been extensively studied all around the world but much has yet to be learnt about the 
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phenomenon. One of the main challenges has long remained in the area of SERS-active 
substrate and in particular, its uniformity and reproducibility in detection. Over the past 
two decades, however, substantial progress has been achieved in the fabrication of 
improved substrates in a highly reproducible fashion due to advances in nanotechnology 
which allowed for the fabrication of various new designs [110, 111]. The standard 
molecules employed for trace level detection by SERS investigators are various dyes, 
such as Rhodamine 6G or crystal violet, [112, 113] used mostly due to their strong 
resonance properties, and benzenethiol [110] used due to its ability to form self-
assembled monolayers (SAMs) on the SERS active area of substrates.  
In this Chapter as part of the overall Raman spectroscopy theme of the thesis, the 
primary focus is on the trace detection of key pharmaceutical and structurally related 
organics rather than dyes and SAMs that are commonly used by others in SERS studies. 
Rather than developing new substrates, the focus will be on SERS detection and 
evaluation of one of a few, to the best of the author’s knowledge, commercialized SERS 
substrates.  
The substrates used are comprised of periodic, photonic crystal arrays of gold-
coated, inverted square pyramidal cavities etched on a silicon wafer to induce surface-
enhanced Raman scattering. In this study SERS was used to detect low concentrations of 
pharmaceutical compounds: griseofulvin, the active ingredient in antifungal drug, and 
acetaminophen or N-acetyl-p-aminophenol (APAP), a common pain medication; and the 
aromatic organic energetic compound 2,4,6 trinitrotoluene (TNT), and non-aromatic 
organic energetic compounds: 1,3,5-trinitroperhydro-1,3,5-triazine (RDX), and 1,3,5,7-
tetranitro-1,3,5,7-tetrazocane (HMX). SERS is induced on these substrates by the strong 
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interaction of trapped surface plasmons (see section 5.2) within the void architecture of 
the cavities with incident visible and near-infrared laser radiation. As discussed below, 
highly reproducible surface-enhanced Raman spectra on the SERS-active substrates were 
obtained using 785 nm laser excitation at a detection level of 8.8x10-5 M for TNT and 
detection levels of 10-4 M for non-aromatic RDX and HMX. A lower detection level of 
5.6x10-7 M was achieved for griseofulvin and the lowest, 1.3x10-8 M, was obtained for 
acetaminophen. The data for these molecules were compared to those obtained for the 
SERS standard dye Rhodamine 6G recorded under the same conditions.   
Raman spectra of species at extremely low concentrations are those of the free 
molecules since the ordered lattice of a crystalline solid does not exist at that 
concentration level [106, 112]. In the case of APAP and griseofulvin adsorbed on the 
engineered photonic crystal substrates, the surface enhanced spectra were different from 
that of the molecular conformation in their most stable polymorphic forms. However, for 
energetic compounds with similar molecular dimensions as the pharmaceuticals, but with 
nitro and nitramine groups attached, such as, TNT, RDX, and HMX, the SERS spectra 
were essentially the same as the molecules in their known stable crystal forms.  
    
5.2 The SERS Mechanism 
Surface enhanced Raman scattering (SERS) when coupled with chemically induced 
enhancement due to molecular electronic transitions, is a powerful analytical tool which 
can provide chemical and molecular structure information as well as trace level detection 
comparable to that achieved by fluorescence spectroscopy [113-116]. Understanding how 
the local electromagnetic environment modulates the spectral response in SERS has been 
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an area of growing interest since the initial discovery of SERS [107, 108, 117, 118]. It 
has become increasingly clear that localized surface plasmons, which are quantized 
excitations associated with free electron oscillations in a metal or so-called “hot spots” 
from nanostructures like colloidal aggregates or crystal junctions and edges in 
nanostructured gold or silver coated substrates give rise to intense local fields that are 
responsible for the electromagnetic contribution to SERS [119-121] with enhancements 
up to 1012. Another two or three orders of magnitude of chemically-induced enhancement 
can occur either due to resonance Raman scattering or from charge-transfer transitions 
resulting from the formation of a molecule-metal surface bond. The overall enhancement 
factor of 1014 to 1015 therefore makes single molecule detection possible by SERS. “Hot 
spots” typically occur at randomly formed locations or fractal structures that can 
fortuitously provide the configurations necessary for electromagnetically-induced SERS. 
These effects together with variations in surface roughness and particle size on 
nanostructured substrates [122] lead to irreproducibility in detection applications.  
As a result of improvements in nanofabrication techniques, a number of regularly 
ordered periodic nanostructures have been prepared for surface-enhanced Raman 
spectroscopy [123, 124]. In spite of these efforts a number of challenges remain, 
particularly in the scalable and reproducible production of inexpensive, rugged and 
reusable SERS-active substrates. A new class of lithographically fabricated substrates 
comprised of a periodically arrayed photonic crystal void architecture capable of 
supporting trapped plasmons was initially fabricated by Perney et al [111] and 
commercialized as Klarite® by Mesophotonics Ltd (now owned by Renishaw Diagnostics 
Ltd). In this chapter the author will discuss the application of these highly robust 
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substrates for the SERS detection of low concentrations of the following widely used 
molecules:  
 Griseofulvin and acetaminophen or N-acetyl-p-aminophenol (APAP) used as 
active ingredients in the pharmaceutical industry.  
 Aromatic trinitrotoluene (TNT), and the non-aromatic nitramines: 1,3,5-
trinitroperhydro-1,3,5-triazine (RDX) and 1,3,5,7-tetranitro-1,3,5,7-tetrazocane 
(HMX) used world-wide as the active ingredient in energetic formulations. 
 
The differences in detection limits and surface-enhanced Raman spectra observed for 
these compounds and a qualitative explanation for these differences will be provided in 
the following sections.     
5.3 Klarite®  SERS Substrates 
Klarite® SERS substrates consist of a periodic square lattice of inverted square pyramidal 
pits as shown by the scanning electron microscope image in Figure 5.1 (a). The pits are 
produced by conventional photolithography using a silicon dioxide mask on a (100) 
oriented silicon wafer. KOH was used to preferentially etch the (111) planes to give a 
periodic array of inverted pyramidal pits. The pitch or periodic separation of the pits 
formed ranged from 0.7 μm to 1.0 μm. A uniform 300 nm layer of gold was sputtered on 
the wafer after completion of the etching process to give a smooth coating on the pit 
walls and the flat regions between the pits. The substrate design allows the tunable 
plasmon bands to be in resonance with commonly used excitation 632 and 785 nm 
wavelengths of Raman spectrometers.  The absence of surface Raman enhancement (see 
Figure 5.3) from the coating away from the etched pits shows that the overall coating, 
even in the pits, is smooth and therefore does not excite SERS. A tapping mode atomic 
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force microscope (AFM) image of a gold-coated substrate was obtained using a 
Nanoscope III MultiMode Scanning Probe Microscope and shown in Figure 5.1 (b). The 
reproducibility of the SERS signal across the active area was investigated by Perney et al 
[111]. 
 
(a) 
 
 
 
 
 
 
 
 
 
 
(b) 
 
 
 
 
 
 
 
 
 
Figure 5.1 (a) Top view scanning electron microscope (SEM) image showing 2 m wide 
inverted pyramids, and (b) A 10 mm wide atomic force microscope (AFM) image 
showing the inverted pyramidal pits of the photonic crystal SERS substrate with a 300 
nm thick gold layer. Blow ups of the pits and the region between the pits are shown on 
the images to the right.  
 
 
r
h
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5.4 Experimental Details 
Raman Spectroscopy: Raman scattering experiments were carried out using a 
Mesophotonics SE 1000 Raman spectrometer with a 250 mW near-infrared laser emitting 
at 785 nm and a 130 µm diameter spot size. The system operates with an automated XYZ 
stage and a video camera for easy visualization of the sample. A typical acquisition time 
used was 10 seconds per scanned spectrum with the data averaged over 10 scans.  
Preparation of Solutions: Solutions of the pharmaceutical and energetic compounds 
under investigation were prepared in high purity solvents (from Sigma Aldrich): 
griseofulvin (Sigma-Aldrich) in acetone, APAP (Sigma Aldrich) in acetone, TNT 
(obtained from the US Army) in toluene, RDX (obtained from the US Army), HMX 
(obtained from the US Army) in acetone, and the SERS standard dye Rhodamine 6G 
(Lambda Physik). For each compound, the stock solution was made first and diluted by a 
factor of ten each time to obtain further dilutions. For example in the case of 
acetaminophen, the stock solution concentration was 20 mg/ml (0.13 M); it was diluted to 
obtain concentrations of 2 mg/ml (1.3×10-2 M), 0.2 mg/ml (8.81×10-3 M), 0.02 mg/ml 
(8.81×10-4 M), 0.002 mg/ml (8.81×10-5 M), 0.0002 mg/ml (1.3×10-6 M),0.00002 mg/ml 
(1.3×10-7 M), and 0.000002 mg/ml (1.3×10-8 M). A micro-pipette was used to deposit   
0.1 µl of solution on the active region (Figure 5.1) and allowed to dry quickly at room 
temperature in air. The spectrum of a pristine SERS substrate was similarly recorded; 
baseline subtracted from the raw data and processed using the ACDLABS 10.0 software 
from Mesophotonics, to obtain the spectra shown.    
Amorphous griseofulvin was prepared by melting a small amount of crystalline 
griseofulvin on a glass slide heated on a hot plate at 220ºC until completely melted, and 
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cooled at room temperature to form a solid film. The Raman spectrum of amorphous 
griseofulvin was recorded immediately upon solidification of the film. The appearance of 
a strong peak at 656 cm-1 and the absence of a peak at 820 cm-1 in the spectrum was used 
to confirm the formation of amorphous griseofulvin.[23] The same procedure was used 
for preparing amorphous acetaminophen and obtaining its Raman spectrum.   
 
5.5 The SERS Enhancement Factor (SERS EF) 
The effectiveness of the Klarite substrate was determined by measuring the enhancement 
factor (EF) expressed by the following equation [125]: 
 
SERS EF [Raman Shift (cm-1)] = 
volSERS
SERSvol
I  N
I  N


                 (5.1) 
 
Nvol  – Number of molecules in the probed volume area  
Nsers – Number of molecules in the probed SERS substrate area 
I vol – Intensity of the Raman signal from the probed volume 
Isers – Intensity of the Raman signal form the SERS substrate. 
To determine SERS EF, the limit of detection for all investigated molecules was 
measured by both conventional and surface-enhanced Raman spectroscopy and compared 
with that for Rhodamine 6G (R6G), which was used as a SERS standard in this study.   
Using conventional Raman spectroscopy, the lowest level of detection for R6G 
solution was determined to be 0.001004 mol/L or 1x10-3 M which corresponded to the  
4.1 x 1013 number of molecules (Nvol) in the given volume of the probed solution (Vbeam) 
and was calculated as follows: 
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Vbeam = mlcmr 73333 105.6)105.6(
3
4
3
4     
Nvol = 13
7
233 101.4
10
105.610022.6101 


ml
mlMx  
The intensity of the Raman line (Ivol) was calculated by integrating the area under the 
spectral peak recorded for the lowest detectable concentration by conventional Raman 
measurement. Ivol for R6G was found to be 7533 counts/seconds.   
For surface-enhanced Raman spectroscopy, the lowest detectable concentration 
for R6G was measured to be 0.001004 x 10-6 mol/L or 1.x10-9 M. Similar calculations 
were followed for the SERS probed volume (VSERS) to calculate the number of molecules 
in that volume (NSERS). SERS volume (VSERS) was calculated based on the substrate area 
probed by the laser, the number of wells probed in that area and their corresponding 
volumes [Figure 5.1 (a)]. For the number of wells probed: 
Wells probed = 3318
well
laser
A
A  
Since, the volume of each well corresponds to: 
Vwell = 39.0
3
mAh   
Then, the volume probed by the laser beam on the SERS substrate is: 
VSERS = mlwellsm 93 101.333189.0   
This corresponds to the number of molecules probed on SERS substrate given by: 
NSERS = 5
9
239 109.1
10
101.310022.6101 


ml
mlMx  
The SERS intensity (ISERS) was calculated in similar fashion as Ivol except the 
integrated area under the spectral peak corresponded to the lowest detectable  
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Table 5. 1 Enhancement Factors and Contributing Concentrations of Probed Compounds 
to the SERS Recorded Spectra  
 
Compound Enhancement Factor Limit of Detection (M) 
   
R6G 1.0x108  1.1x10-9  
TNT 6.1x105  8.8x10-5  
   
Griseofulvin 
APAP 
1.2x108 
5.4x108  
5.6x10-7 
1.3x10-8  
   
 
concentration of each of the investigated compounds using the SERS substrate. 
Rhodamine 6G gave an enhancement factor of 108 from equation 5.1 as listed in Table 
5.1 together with enhancement factors for TNT, griseofulvin and APAP. Enhancement 
factors for HMX and RDX were not obtained because for safety and security reasons 
only limited amounts of these compounds were available. 
 
5.6 Raman Spectra of Investigated Molecules on the SERS Substrates 
Surface enhanced Raman spectra of griseofulvin, APAP, TNT, RDX, and HMX were 
taken on the SERS substrates described above using near-infrared excitation at 785 nm.  
The goal of this work was to examine and evaluate the spectra obtained and determine 
the SERS sensitivity and enhancement factors using this new generation of photonic 
crystal substrates. The highly ordered array of inverted square pyramids covered with 
gold results in highly reproducible Raman signals at low analyte concentrations. The 
substrate design supports the generation of surface plasmon standing waves localized 
inside the bottom of each pit, its sidewalls and the connecting surface bridges between 
the pits [Figure 5.1 (a)]. As a result, the electromagnetic fields are found along the 
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surface bridges and inside the inverted pyramidal pits [111] leading to effective increase 
in magnitude of both incoming radiation and scattered fields. The total SERS 
enhancement is a product of two mechanisms as mentioned above: electromagnetic field 
(EF) enhancement from the strong coupling between the surface plasmons on the 
substrate and molecular vibrational excitations, and chemical enhancement (CE) 
associated with the more localized  molecule-surface charge transfer interaction [11]. The 
surface irregularities of the SERS substrate can significantly affect the enhancement 
factor and reproducibility but are minimized in the photonic crystal substrates used here 
by engineering of the pit structure. Reproducibility of the Raman signal across the 
substrate is reported with less than 10% RSD for a substrate with SAMs of benzenethiol 
[111].  Reports using SAMs model systems for a range of SERS substrates show a high 
degree of reproducibility [110, 126]. The results have been used to understand the 
selective enhancement or loss of intensity of Raman lines by identifying molecule-
substrate orientation [127, 128]. SAMs result in monolayer surface bonding which 
strongly influences the homogeneous distribution of the molecules on a SERS substrate 
to provide more controllable electromagnetic enhancement. Other studies, however, have 
shown that this selectiveness in enhancement of Raman lines can be attributed to 
increased Raman scattering cross sections caused by changes in molecular electronic 
structure due to surface bonding rather than molecular orientation vis-a-vis the substrate 
[11, 126, 129].  Examining the behavior of various organic compounds discussed below 
on the arrayed photonic crystal SERS substrates, it is noticed that some of the SERS 
Raman spectra vary from that of the bulk material. A possible explanation for this 
behavior is discussed. 
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 TNT 
The Raman spectrum for solid TNT in the 200 to 2000 cm-1 fingerprint region is shown 
in Figure 5.2 (A). Important spectral features consist of a somewhat broadened, intense 
line peaked at 1362 cm-1 assigned to the symmetric stretching -NO2 mode of the TNT 
molecule, a doublet at 822 cm-1 and 791 cm-1 assigned to scissoring and wagging motions 
respectively of the -NO2 groups, and lines at 1618 cm-1  and 1535 cm-1 assigned to the 
aromatic C=C stretching and asymmetric stretching -NO2 modes, respectively [130]. The 
broadening of the line due to the symmetric stretching -NO2 mode is due to unresolved 
splitting of this mode caused by a breakdown of the ring symmetry in TNT due to 
electron donation of the methyl group to the aromatic ring [130]. The lines between 822  
and 1362 cm-1 can be assigned to in-plane ring bending, CH3 deformation and C-N 
stretching modes of TNT, whereas the lines below 791 cm-1 can be contributed to out-of-
plane ring bending, ring distortion and C-CH3 wagging modes [131]. 
(A)                                                               (B)                                               
 
 
 
 
 
 
Figure 5.2 (A) Background-subtracted solid TNT spectrum with its molecular structure 
attached, and (B) SERS from samples prepared by evaporating 0.1 µl solutions of various 
concentrations of TNT in toluene. 785 nm laser radiation and 10 seconds acquisition time 
were used for recording the spectra for: (a) 2 mg/ml or 8.81x10-3 M solution, (b) 0.2 
mg/ml or 8.81x10-4 M solution, (c) 0.02 mg/ml or 8.81x10-5 M solution and (d) 0.002 
mg/ml or 8.81x10-6 M solution.  
(a) 8.81 x 10M
-3
 
(b) 8.81 x 10M
-4
 
(c) 8.81 x 10M
-5
 
(d) 8.81 x 10M
-6
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Background-subtracted, 10 seconds SERS Raman spectra in the 100 to 2000 cm-1 
range taken from the active region of the SERS substrates from TNT solutions of 
different concentrations in toluene down to 0.002 mg/ml or 8.81x10-6 M, are shown in 
Figure 5.2 (B). All Raman features are evident in the 0.02 mg/ml spectrum while the 
stronger Raman features of solid TNT are discernable in the 0.002 mg/ml spectrum which 
is equivalent to 8.81 x 10-6 M TNT in toluene. The weaker features of the 0.002 mg/ml 
spectrum, however, become evident at higher integration times. It is estimated that the 
level of detection for TNT is about 0.002 mg/ml solution or 8.8 x 10-5 M. The 
enhancement factor of 105 is calculated for TNT using equation 5.1 above as listed in 
Table 5.1. No Raman spectra at these low concentration levels are observed from the flat 
inactive region of the substrate away from the inverted square pyramidal cavities.   
Comparison of the solid to the SERS Raman data indicates that the overall 
spectral distribution of the lines is the same. This is also true for data recorded using 
632.8 nm excitation. Small shifts in line positions are however observed in the SERS 
data. For example, the line at 1362 cm-1 in the solid state spectra assigned to the 
symmetric -NO2 stretching mode shows a highly reproducible down-shift in the SERS 
data by 3-5 cm-1 probably due to the absence of strong intermolecular interactions in the 
dilute phase sampled by SERS.   
 
RDX and HMX 
The Raman spectra for highly pure solid RDX and the stable -polymorph of HMX used 
in this study are shown in the 250 to 2000 cm-1 fingerprint region in Figures 5.3 (A) and 
5.4 (A), respectively. The spectra consist of a complex pattern of several more intense 
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lines than those in the same region for TNT. The lines in the 250 to 800 cm-1 region for 
both RDX and HMX can be assigned to ring deformation, NO2 scissoring, rocking and 
wagging motions [132, 133]. The strongest line is at 882 cm-1 in RDX and at 832 cm-1 in 
the larger HMX molecule. In RDX this line can be assigned to a mode consisting of C-N 
stretching, N-N stretching and –CH2 rocking [132]. There are also two nearby intense 
lines in HMX at 879 and 949 cm-1 which been assigned to ring breathing or stretching 
modes in HMX by Iqbal et al [133] and in RDX by Ciezak and Trevino[132]. The line at 
1309 cm-1 in RDX and at 1311 cm-1 in HMX, and lines between 1500 and 1600 cm-1 in 
RDX and HMX can be assigned to the symmetric and asymmetric stretching modes, 
respectively, of the -NO2 groups [133].  
The surface-enhanced Raman spectra for RDX and HMX taken from the SERS 
active region of the substrate are shown in Figures 5.3 (B) and 5.4 (B), respectively. The 
limit of detection of the primary Raman lines is 0.1 g/ml or 4.5 x 10-4 M which is about 
two orders of magnitude higher or less sensitive than the limit of detection for TNT. This 
suggests that the plasmon-phonon coupling responsible for SERS is much higher for the 
aromatic TNT molecule with more delocalized electrons. Moreover, the surface-
enhanced spectra of RDX and HMX have fewer lines relative to the solid state spectra, 
probably because the spectra are in the highly dilute molecular phase and therefore the 
strong intermolecular hydrogen bonding, O∙∙∙O and O∙∙∙C interactions present in the solid 
are absent. The strongest Raman line at 882 cm-1 in solid RDX downshifts by 6 cm-1 
similar to the behavior observed for the -NO2 symmetric stretching mode in solid TNT 
which is the strongest Raman line in the TNT spectrum. In HMX however the line at 949 
cm-1 downshifts by 12 cm-1 whereas the line at 832 cm-1 increases in frequency by   
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(a) 4.5 x 10-3M 
(b) 4.5 x 10
-4M 
(c) 4.5 x 10
-5
M 
(A)                                                             (B) 
   
 
 
 
 
 
 
Figure 5.3  (A) Background-subtracted solid RDX spectrum with its molecular structure 
attached and (B) SERS from sample prepared by drying 0.1 µl solutions of various 
concentrations of RDX in acetone, using 785 nm laser radiation and 10 seconds 
acquisition time: (a) 1 mg/ml or 4.5 x 10-3 M solution, (b) 0.1 mg/ml or 4.5 x 10-4 M 
solution, and (c) 0.01 mg/ml or 4.5 x 10-5 M solution.  
 
(A)                                                             (B)  
 
 
 
 
 
 
 
Figure 5.4 (A) Background-subtracted solid -HMX spectrum with its molecular 
structure attached, and (B) SERS from sample prepared by evaporation of 0.1 µl 
solutions of various concentrations of -HMX in acetone, using 785 nm laser radiation 
and 10 seconds acquisition time: (a) 1 mg/ml or 3.3 x 10-3 M solution, (b) 0.1 mg/ml or 
3.3 x 10-4 M solution, and (c) 0.01 mg/ml or 3.3 x 10-5 M solution. 
 
(a) 3.3 x 10
-3
M 
 
(b) 3.3 x 10
-4
M 
 
(c) 3.3 x 10
-5
M 
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12 cm-1 due to structural renormalization in the molecular phase. Another interesting 
feature is that the line assigned to the -NO2 symmetric stretching mode increases in 
frequency relative to the solid in SERS both for RDX and HMX by 5 to 7 cm-1 in contrast 
to the behavior of the corresponding mode in TNT where there is a downshift.  
 
Griseofulvin 
The Raman spectrum of solid griseofulvin in the 100 to 210 cm-1 region are shown in 
Figure 5.5 (A) and are in agreement with the spectrum reported by Zarow et al [23]. 
Griseofulvin is an aromatic organic but unlike TNT does not have strongly 
electronegative nitro substituent groups.  A series of background-subtracted SERS 
Raman spectra of drop deposited griseofulvin of concentrations down to 0.0002mg/ml or 
5.6 x10- 7M and the normal Raman spectrum of amorphous griseofulvin, are shown in 
Figure 5. 5 (B). The enhancement factor of 108 was calculated based on equation (5.1) 
and is shown in Table 5.1. Characteristic Raman lines for the SERS spectra of 
griseofulvin molecules show major differences when compared to the Raman spectra of 
solid, crystalline griseofulvin as shown in Table 5.2. A detailed examination of all SERS 
spectra shows strong resemblance of these spectra with the normal Raman spectrum of 
amorphous griseofulvin. Upon crystalline-to-amorphous transition, the distinctive Raman 
line at 820 cm-1 corresponding to the cyclohexanone ring stretching mode is completely 
lost [23] which is also the case for the SERS spectra. In addition, the triplet in the 650 
cm-1 spectral region of the crystalline form transforms into a broad singlet at 646 cm-1 in 
the SERS spectra. The lines for the –CH in-plane deformation in the solid state Raman 
spectra show a highly reproducible 2 to 5 cm-1 upshift in the SERS data and are more 
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intense than the corresponding Raman lines in amorphous APAP discussed below. 
Similar frequency upshifts are observed for the -CH3 and -CH2 deformation, and C=O 
and C=C stretching modes as summarized in Table 5.2 which indicate increases in C-H, 
C=O and C=C bond force constants on going from the crystalline to the molecular state. 
Increases in line frequencies are also seen in part on going from the crystalline to the 
amorphous phase since the amorphous phase of an organic can be considered to be a 
frozen liquid with randomly oriented molecules and no long range inter-molecular 
coherence [25].    
 Even though the EF for griseofulvin and APAP are of the same order (108), the 
corresponding detection sensitivities are different, 10-7 M versus 10-8 M, respectively. 
This can be related to the presence of electron withdrawing and donating groups on the 
respective aromatic benzene rings in each of the molecules which can influence the 
electron density on the ring. In griseofulvin, the presence of an -OCH3 moeity can result 
in transfer of some of the substituted group electrons to the ring via a resonance effect. 
On the other hand, in case of griseofulvin, the presence of a strong electronegative -Cl 
group (similar to –NO2 groups in TNT) will promote withdrawal of ring electrons via the 
sigma bond to decrease electron density on the aromatic ring. In the case of APAP, 
however, the aromatic ring is bonded to electron donating groups, –OH and –H-N-C=O 
and hence electron density on the aromatic ring will increase, resulting in increased 
coupling with surface plasmons and higher SERS sensitivity in agreement with 
experimental results.   
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(c) 5.6 x 10
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(e) 5.6 x 10
-7
M 
(A)                                                        (B) 
 
 
 
 
 
 
 
 
 
 
Figure 5.5 (A) Solid spectrum of griseofulvin with its molecular structure attached, (B) 
SERS from sample prepared by evaporating 0.1 µl solutions of various concentrations of 
griseofulvin in acetone, using 785 nm laser radiation and 10 seconds acquisition time: (a) 
20 mg/ml or 5.68 x10-2 M solution, (b) 0.2 mg/ml or 5.68 x10-4 M solutions, (c) 0.02 
mg/ml or 5.68 x10-5 M solution, (d) 0.002mg/ml or 5.68 x10-6 M solution and (e) 0.0002 
mg/ml or 5.68 x10-7 M solution. Top Raman spectrum shows melt-quench amorphous 
griseofulvin.  
 
Table 5.2 Raman Frequencies and Qualitative Mode Assignments in Crystalline, 
Amorphous and SERS Griseofulvin  
 
Crystalline  
Frequency (cm-1)
Amorphous 
Frequency (cm-1) 
SERS 
Frequency (cm-1) 
Qualitative Assignments  
428 426 428 C-Cl deformation 
628 - - C-Cl stretching, ring deformation 
650 647 646 C-Cl stretching  
820 - - Cyclohexanone ring stretch 
968 967 968 Benzene ring asymmetric stretch 
1178 1178 1181 Ring vibration, -C-O-C stretch 
1213 1217 1220 -CH in-plane deformation 
1238 1239 1242 -CH in-plane deformation 
1349 1350 1354 - CH3 and -CH2 deformations 
1618 1613 1614 C=O mixed with C=C stretch 
1659 1663 1663 C=C stretch in cyclohexanone 
1707 1706 1709 C=O stretch in benzofuran 
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Acetaminophen (APAP) 
APAP, which is a purely aromatic molecule like griseofulvin, can exist in three 
polymorphic forms besides its solid amorphous phase [73]. The monoclinic yype I phase 
crystallizes as the most thermodynamically stable form. Its solid Raman spectrum in this 
stable phase in the 200 to 2000 cm-1 fingerprint region is shown in Figure 5.6 (A). The 
characteristic Raman lines at 1650 cm-1 and 1616 cm-1 are assigned to the C=O stretching 
and the N-H deformation modes, respectively, as indicated in Table 5.3. The line at 1562 
cm-1 is attributed to the H-N-C=O amide carbonyl group vibration, the line at 1324 cm-1 
to the C-H bending mode whereas the line at 1169 cm-1 is due to the C-H deformation 
vibration. The strongest Raman lines are in the 800 cm-1 spectral region where 
characteristic modes for the phenyl ring stretch and aromatic C-H out of plane vibration 
exist at 796 cm-1 and 856 cm-1 respectively [74, 84]. 
Surface enhanced Raman spectra of APAP taken from the active region of the 
substrate show noticeable differences from the solid Raman spectra of the drug mainly 
because as in griseofulvin, the SERS spectra correspond to those of APAP molecules. 
The limit of detection for the primary enhanced line at 856 cm-1 is 2 x 10-6 g/ml or 1.3 x 
10-8 M, which gives an enhancement factor of 108 based on equation (5.1). The C=O 
stretching, N-H deformation and HN-C=O bending-stretching modes of the solid Raman 
spectrum are very weakly enhanced and can be only detected at high concentrations of 2 
mg/ml and cannot be observed for further dilutions as shown in Figure 5.6 (B). It is 
interestingly noticed that the strongest enhancement is recorded for the mode 
corresponding to the aromatic phenyl ring vibrations in the 800 cm-1 region. The SERS  
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(A)                                                             (B) 
 
 
 
 
 
 
 
Figure 5.6 (A) Normal Raman spectrum of (a) solid and (b) amorphous acetaminophen 
with molecular structure attached, and (B) Background-subtracted SERS spectra from 
sample prepared by evaporating 0.1 µl solutions of various concentrations of 
acetaminophen in acetone, using 785 nm laser radiation and 10 seconds acquisition time. 
The SERS spectra are for: (a) 2 mg/ml or 1.32 x 10-2 M, (b) 0.02 mg/ml or 1.32 x 10-4 M 
solution, (c) 0.0002 mg/ml or 1.32 x 10-6 M solution, (d) 0.000002 mg/ml or 1.32 x 10-8 
M solution. 
 
spectral features resemble the normal Raman spectrum of amorphous acetaminophen as 
in griseofulvin, indicating the absence of intermolecular interactions.  The highly 
reproducible up- and down-shifts of several Raman lines in the SERS spectra are 
summarized in Table 5.3. The strongest Raman line at 856 cm-1 upshifts by 4 cm-1 similar 
to the behavior of the C-H out-of-plane bending mode for amorphous APAP. The 
remaining Raman lines in the SERS spectra show 2 cm-1 to 5 cm-1 downshifts and agree 
with shifts of these lines on going from the crystalline to the amorphous phase. Two 
Raman lines, however, show even higher downshifts than the corresponding amorphous 
phase Raman lines. These lines are the out-of-plane deformation mode at 326 cm-1 which 
decreases in frequency by 5 cm-1 in the SERS spectra, whereas only a 2 cm-1 downshift is 
seen for this line in the amorphous phase. Similarly to -N-H deformation mode at 1616 
(a) Amorphous 
 
 
 
 
(b) Crystalline 
 
(a) 1.32 x 10
-2
M 
(b)  1.32 x 10
-4
M 
(c)   1.32 x 10-6M 
(d)   1.32 x 10
-8
M 
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cm-1 decreases in frequency by 5 cm-1 in the SERS spectra and only 2 cm-1 in the 
spectrum of the amorphous phase. This trend is opposite to what is seen in griseofulvin, 
where most of the SERS lines showed upshifts suggesting increases of the interatomic 
force constants. This behavior may be associated with differences in molecular structure 
(see discussion in griseofulvin section).  
Table 5.3 Raman Frequencies and Qualitative Mode Assignments in Crystalline, 
Amorphous and SERS Acetaminophen  
Crystalline  
Frequency (cm-1)
Amorphous 
Frequency (cm-1) 
SERS 
Frequency (cm-1) 
Qualitative Assignments  
326 324 321 Out-of-plane ring deformation 
388 382 382  
462 - - Out-of-plane ring deformation 
501 502 499 Out-of-plane ring deformation 
649 643 643 In-plane ring deformation 
796 794 794 phenyl ring stretch [74] 
856 859 859 C-H out-of-plane bend 
1169 1167 1166 C-H in-plane bend 
1237 1231 1230 C-N stretch 
1278 1273 1273 O-H and C-O combination, (ar) C-N 
stretch         
1324 1321 1320 C-H bend 
1371 1372 1369 -CH3 umbrella mode 
1562 - - -H-N-C=O stretch [74]  
1616 1614 1611 -N-H deformation [74] 
1650 1660 - C=O stretch [74] 
 
5.7 Conclusions 
The results presented here using SERS substrates comprised of arrays of inverted 
pyramidal pits for three types of energetic and pharmaceutically active organic molecular 
crystals show that the SERS detection sensitivity or enhancement factor is the lowest for 
the non-aromatic nitramine compounds RDX and HMX and nitro-substituted aromatic 
TNT, where the enhancement factor approaches 106. Increase of enhancement factors by 
another 2 orders of magnitude is achieved for purely aromatic pharmaceutical molecules 
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griseofulvin and APAP, and also for the dye molecule Rhodamine 6G. The enhancement 
factors achieved are however many orders of magnitude lower than single molecule 
detection levels near 1014 achieved for dye molecules on “hot spot” sharp nanoscale tips 
or between nanometer-spaced nanoparticles.  On the other hand since the plasmons are 
localized within cavities in the SERS substrates used, the plasmon field distributions are 
matched to reach deep inside the mid-sized molecules probed here to provide, unlike for 
“hot spot” nanostructures, a high degree of reproducibility of the spectral signals 
obtained. 
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CHAPTER 6 
SUMMARY, CONCLUSIONS AND SUGGESTED FUTURE WORK 
 
The work discussed in this thesis is focused on themes related to the application of 
Raman spectroscopy as a sensing and non-destructive characterization tool for use 
primarily in the pharmaceutical industry. Although the complementary tool of near 
infrared spectroscopy is more widely used in this industry, Raman techniques involving 
fiber optics are slowly emerging as a methodology to provide not just sensing but also 
molecular and crystal phase science that are of critical importance for quality-controlled 
drug manufacture.  
In Chapter 1, an introduction and a brief overview of the quality requirements 
involving PAT (Process Analytical Technology) initiative, was presented with an 
emphasis on real time quality control and better understanding of novel materials down to 
the nanoscale level. The analysis of manufactured products requires some of the most 
effective and information-rich tools of solid-state science. Raman spectroscopy, as a 
highly advanced, molecule-specific method, was presented in its theoretical aspects and 
shown to be an excellent method for this task, particularly for the challenges of 
understanding molecular interactions in complex solids. Complementary methods used in 
this work were also briefly discussed.  
Structural disorder induced by cryogenic milling and by heating to the amorphous 
phase in the active pharmaceutical ingredient, griseofulvin primarily studied by Raman 
spectroscopy with contributions from small (using Synchrotron techniques) and wide 
angle X-ray powder diffraction (XRPD), fluorescence spectroscopy and differential 
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scanning calorimetry (DSC) are presented in Chapter 2. A broad, novel frequency-
independent scattering background superimposed on the Raman spectra observed 
together with changes in intensities and splittings of some of the Raman lines due to 
lattice (inter-molecular) and molecular modes are interpreted and discussed in detail. In 
the cryomilled samples this strong background can be deconvoluted into two 
components: one due to lattice disorder induced by cryomilling and the other due to Mie 
scattering from nanosized crystallites. Related but more intense background scattering for 
thermally produced amorphous griseofulvin can be fitted to a single Lorentzian function 
and attributed to lattice disorder. Comparison of Raman and fluorescence data showed no 
relation of the Raman background intensity to impurity- or molecular defect- induced 
fluorescence as fluorescence measurements showed an intrinsic fluorescence signal in as-
received griseofulvin that does not correspond to the inelastic background in the Raman 
spectra, and moreover decreases in intensity on cryomilling. Broad two-component 
background scattering for cryomilled griseofulvin was also observed by wide-angle 
XRPD measurements and attributed to lattice disorder but at much longer correlation 
lengths than in Raman scattering. Disorder at two correlation lengths indicated by the 
XRPD data was consistent with the background scattering components in the Raman data 
associated with lattice disorder and Mie scattering. Persistence of this disorder to even 
longer lengths is evident in small-angle Synchrotron XRPD data on micronized 
griseofulvin taken as a function of temperature from the crystalline to the amorphous 
phase. Effective identification of process induced structural disorder is likely to be an 
important aspect of pharmaceutical formulation manufacturing. Disordered domains 
formed can progressively transform during processing into long range disorder and result 
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in polymorphs or amorphous phase formation that would impact the quality of the dosage 
form produced.    
Different aspects of polymorphism of the widely used model drug acetaminophen 
(APAP) are considered in Chapter 3. Also in this chapter and in the related Appendix A, 
the molecular and lattice vibrations observed in APAP in its various forms and type I 
APAP in single crystal form, respectively, were measured and interpreted. Oriented 
single crystal Raman data and its temperature dependence were measured for the first 
time to the best of our knowledge in order to understand milling behavior. APAP exists in 
three different crystalline arrangements and a disordered amorphous form. The type II 
polymorph is of potential pharmceutical interest due to its better tabletting characteristics 
relative to the stable type I polymorph – however, as normally prepared, it is not stable 
enough for long term use as a pharmaceutical product. In this research new interfaces 
were successfully created in type I APAP by micronization and by dry-coating with 
nanosized silica to significantly extend the stability of type II obtained from this modified 
type I phase. Raman spectroscopy, and XRPD, SEM and dissolution techniques were 
employed to monitor and characterize the stabilized phase. One interesting result 
obtained was that with increasing time a diffuse scattering background appeared in the 
Raman spectra which varied with time. This scattering is similar to what was seen in 
cryomilled griseofulvin and was qualitatively attributed to the slow growth and annealing 
of nanosized nuclei of the stable type I polymorph in the matrix of the stabilized type II 
APAP phase at ambient conditions. Intrinsic dissolution data were also measured and 
showed an improvement in mass release for type II APAP obtained from micronized and 
nanocoated type I APAP.  
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Raman sensing and imaging of pharmaceutical dosage and manufacturing forms, 
involving the model API griseofulvin, are the topics discussed in Chapter 4.  Monitoring 
of thin gel griseofulvin films fabricated from micronized powders and nanosuspensions 
provided analytical process understanding of molecular interactions at the micro- and 
nano-scale. Findings and scientific understanding, such as those described in Chapters 2 
and 3, were used to help interpret off-line Raman mapping of these novel dosage forms. 
Raman mapping complemented by near infrared chemical imaging (NIR-CI), was used to 
investigate solid-state morphology and agglomerates of the embedded particles in the 
polymeric matrix of the gel. NIR-CI provides scrutiny at comparatively larger scales than 
Raman imaging, to show the absence of large clusters and various degrees of drug 
dispersion and aggregation throughout the film area covered with the drug. Raman 
imaging evaluated dispersion at sub-micron levels and confirmed crystallinity of the 
embedded drug for films fabricated with micronized and nanosized griseofulvin 
suspensions based on the presence of characteristic Raman lines for crystalline 
griseofulvin in the 500 to 850 cm-1 spectral range. The use of fiber-optic Raman 
spectroscopy for particle size characterization was developed for in-line monitoring of 
griseofulvin nano-suspensions with 300 nm sized particles obtained by media milling. 
The crystallinity of the suspensions and size prediction based on Raman signal intensity 
showed the capability of this technique for on-line quality control during pharmaceutical 
manufacturing.  
Chapter 5 discusses the use of Raman spectroscopy for sensing down to trace 
levels of organic pharmaceutical and energetic solids. Photonic crystals in the form of 
periodic arrays of gold-coated, inverted square pyramidal cavities etched on a silicon 
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wafer were used to induce surface-enhanced Raman scattering (SERS) to detect trace 
concentrations of purely aromatic pharmaceutical compounds griseofulvin and APAP; 
non-aromatic nitramine compounds 1,3,5-trinitroperhydro-1,3,5-triazine (RDX) and 
1,3,5,7-tetranitro-1,3,5,7-tetrazocane (HMX) and nitro-substituted aromatic 2,4,6 
trinitrotoluene (TNT). For griseofulvin and APAP, amorphous-like Raman spectra were 
observed at trace levels (enhancement factor of 108-109) whereas the energetic 
compounds with much lower enhancement factors showed Raman spectra corresponding 
to their crystalline phases with correlated molecules. This suggests that the amorphous 
phase in organics corresponds to uncorrelated molecules in a matrix, although the 
experimental conditions here are well below the single molecule detection limit of about 
1014. It was also shown that since SERS is induced on these substrates by the strong 
interaction of trapped surface plasmons within the micron-scale void architecture of the 
cavities a high degree of reproducibility of the detected signals is obtained unlike for so-
called “hot spot” conditions for single molecule level detection.  
 
FUTURE WORK: 
The following are some topics for future work related to this thesis: 
 Quantitative understanding of the broad inelastic scattering in defected organic 
solids by modeling and simulations 
 Thermal measurements, such as differential thermal calorimetry to determine 
molar heat capacity and understanding the driving force for stabilization of the 
type II polymorph of APAP 
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 Fabrication of tablets by compaction of stabilized type II APAP and use of Raman 
spectroscopy and imaging techniques to evaluate long-term stability  
 Further analysis of images obtained for films fabricated from API (e.g. 
griseofulvin) nanosuspensions would test for precision and accuracy of the 
predictions of component concentrations in thin films and extend it to excipient 
tablets with deposited API. It would also be of interest to develop in-line sensing, 
other than chemical imaging used till now, to characterize film quality during 
production and further optimization of already developed in-line monitoring of 
particle size of API in nanosuspensions by Raman spectroscopy to effectively 
predict the particle size during milling. 
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APPENDIX A 
 
APAP SINGLE CRYSTAL STUDY 
 
 
Using Raman spectroscopy, as discussed in this thesis, lattice and molecular vibrational 
data can be obtained. Although it is not typically done, it would be particularly useful if 
this data can be collected from individual crystals as a function of temperature, pressure 
and crystal orientation. During pharmaceutical processing of organic powders consisting 
of millions of crystallites, mechanical milling is often used to decrease the average 
particle size of weakly water-soluble particles in order to provide solubility. Thermal and 
pressure changes that occur during the milling process can induce structural 
transformations in the milled powders. A temperature and pressure study of a single 
crystal simulates these changes for an individual pharmaceutical crystallite in a powder to 
provide insights into the intra- and inter-atomic forces within the crystal structure. This is 
part of a larger study within the NSF-ERC which includes single crystal X-ray diffraction 
as a function of uniaxial stress at the University of Hawaii coupled with modeling at 
Rutgers University. In this work single crystals of acetaminophen (APAP) grown at the 
University of Hawaii (K. Morris et al) have been studied as a function of temperature up 
to near the melting point and crystal orientation using confocal Raman spectroscopy to 
better understand the effect of milling on structural stability and the possibility of 
inducing polymorph formation. In addition, Raman spectra recorded as a function of 
crystal orientation (determined by the Hawaii group) and structural data in the literature 
on the molecular architecture in the stable type I polymorph allowed more explicit 
assignments to modes of the molecular and lattice vibrations.   
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 Figure A.1 (a), (b), and (c) shows confocal micro-Raman spectra at ambient 
conditions from the main three faces of a rod-like monoclinic single crystal with 4 
molecules per unit cell and P21/a space group symmetry [65] compared with the 
corresponding Raman spectrum of powders of type I APAP. Each face will correspond to 
a unique set of orientations of the APAP molecule in the type I polymorphic structure. 
Figure A.2 (a), (b), and (c) show spectra qualitatively attributed each to one of the main 
faces with Miller indices of (001), (020), and )120( determined by X-ray diffraction.  
The intensity of a Raman line depends on the interaction of the electric vector of the 
incoming radiation with the vibrational eigenvector. The most intense vibration would be 
one where the two vectors are in the same plane.  
 Figure A.1 (a) shows Raman spectra from single crystal APAP with the laser 
beam backscattered from the crystal face labelled face 1 and from APAP powder. The 
Raman spectrum of the powder represents the average Raman scattering from crystallites 
of various orientations. Strong Raman intensity values indicate that the inter- and intra-
molecular vibrations in acetaminophen, particularly the arrowed lines associated with the 
stretching of the aromatic ring, aromatic C-H stretching and C=O vibrations show high 
intensity because they are in the plane of the electric vector of the incident exciting laser 
beam. This is consistent with the molecules being oriented in the (020) plane as shown in 
the insets to Figure A.1 (a). Figures A.1 (b) and (c) show the Raman spectra for faces 2 
and 3 of the single crystal. The Raman intensity distribution for face 2 is substantially 
reduced relative to that of the powder spectrum. This face can be assigned to the 
)120( plane because the aromatic rings in this plane, as shown in the inset, are aligned 
approximately edge-on to the incident beam and therefore only the weaker deformation 
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a
b 
c 
 (020) Plane 
vibrations interact with the electric vector of the incident beam. Face 3 can be assigned to 
the (001) plane because the Raman intensity distribution from this face is similar to that 
of the powder due to the fact that the APAP molecules have an intermediate alignment 
and the electric vector of the incident laser beam interacts with both stretching and 
deformation vibrations.     
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Figure A.1 Raman spectra of three faces of an APAP single crystal at room temperature: 
(a) Face 1, assigned to the (020) plane, shown in inset with corresponding arrangement of 
the APAP molecules, (b) Face 2 assigned to the )120(  plane with corresponding plane of 
molecules in inset, and (c) Face 3 assigned to (001) with corresponding plane of 
molecules in inset. Plane of each face is represented by red sheet. The “ball and stick” 
convention of plane of atoms is used for acetaminophen molecule where grey, red, white, 
and blue labels represent carbon, oxygen, hydrogen, and nitrogen respectively.  
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Study of Single Crystal APAP as a Function of Temperature 
The spectra were recorded with a confocal Raman system (for details see Chapter 2) as a 
function of temperature using Linkam TS1500 heating and cooling stage at each of 
following temperatures T = 25, 72, 101, 130, 154, and 175°C, Figure A.2 (a). The line 
frequencies, particularly those associated with translational modes at low frequency 
broaden and decrease in frequency with softening of the lattice as the temperature rises 
from 25°C to near melting at 175°C, as shown in Figure A.2 (b). Shift in frequency is 
also noticed for the C=O stretch at 1649 cm-1 which is associated with the intermolecular 
type B hydrogen bonding discussed in section 3.4 and shown in Figure A.2 (c). As the 
temperature rises, the line experiences some broadening with upshift in the peak position 
of 2 cm-1, as shown in Figure A. 3 (a) and A. 4, respectively. Interestingly, even at 
temperature values close to melting, (T = 175°C), the linewidths remain relatively narrow 
indicating the presence of ordered intermolecular interactions. Slight change in the peak 
position is most likely due to small local reorientations of the molecules upon heating, 
resulting in the decrease of type B hydrogen bonding and increase in force constant for 
the C=O stretching mode. Larger shifts in the frequency value can indicate transition to 
the type III or amorphous phase as shown in Table 3.1. However, recorded changes in 
peak position and associated peak broadening at close to the melting temperature, show 
no significant amorphous behavior since the heating causes significantly smaller shift, 
less than 9 cm-1, observed for the amorphous phase. Figure A.2 (c) and (d); and Figure 
A.3 (b) and (c), show changes in  peak positions and line broadening due to onset of 
disorder, Figures A. 4, for lines at 3083 cm-1 and 3326 cm-1 associated with C-H and N-H 
stretching modes respectively, show the largest changes with temperature. As indicated in 
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Table 3.1, the C-H vibration of the phenyl ring increases in frequency in the type III 
polymorph of APAP and also in the amorphous phase. Upon heating, however, a 
downshift by 3 cm-1 is observed indicating changes in local inter-molecular potential. By 
contrast, at 175°C, the NH-stretching line at 3326 cm-1 upshifts by a surprisingly large 
value of 12 cm-1 and broadens significantly.  The influence of type A hydrogen bonding 
on the N-H stretching vibration is therefore significant and shows large local changes in 
symmetry around this bond indicating a strong driving force for polymorph formation. It 
would therefore be interesting to study the spectra also as a function of stress in different 
directions in order to see if polymorph formation is induced. 
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Figure A.2 (a) Raman spectra of APAP single crystal, face 1, taken as a function of 
temperature at 25°C, 101°C, and 175°C show expansion of boxed regions: (b) 100 to 450 
cm-1, (c) 1550 to 1750 cm-1, (d) 2850 to 3300 cm-1. 
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(a)                                                       (b)                                              
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Figure A. 3 Evolution of peak frequencies in APAP single crystal with temperature for: 
(a) 1648 cm-1 C=O stretching line, (b) 3083 cm-1 aromatic C-H asymmetric stretching 
line, and (c) 3326 cm-1 N-H stretching line. 
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(a) 1648 cm-1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A. 4 Evolution of peak broadening with temperature for: (a) 1648 cm-1 C=O 
stretching line, (b) 3083 cm-1 aromatic C-H asymmetric stretching line, and (c) 3326 cm-1 
N-H stretching line. 
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